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Study Objectives 
Chlamydiaceae infections are common in pig farming worldwide, and frequently cause 
economic losses (Schautteet and Vanrompay 2011; Schautteet et al. 2013). Four chlamydial 
species have currently been isolated from swine: Chlamydia (C.) suis, C. abortus, C. pecorum 
and C. psittaci. The pig is considered as the natural host for C. suis, which is also the most 
prevalent chlamydial species occurring in these animals. The primary pathogenicity of C. suis 
for the conjunctiva, respiratory system, gastrointestinal and urogenital tract has been 
demonstrated in various experimental infection studies in gnotobiotic and conventionally 
raised pigs (Rogers and Andersen 1996; Rogers et al. 1996; Rogers and Andersen 1999; 2000; 
Sachse et al. 2004; Reinhold et al. 2008; Guscetti et al. 2009). Moreover, natural chlamydial 
infections in pigs have been associated with conjunctivitis, arthritis, pericarditis, polyserositis, 
pneumonia, enteritis, diarrhea and reproductive failure (Willigan and Beamer 1955; Sarma et 
al. 1983; Woollen et al. 1990; Zahn et al. 1995; Andersen 1998; Eggemann et al. 2000b). 
Nevertheless, the majority of chlamydial infections in pigs is believed to be subclinical 
(Pospischil and Wood 1987; Szeredi et al. 1996; Nietfeld et al. 1997; Hoelzle et al. 2000; 
Camenisch et al. 2004a; Englund et al. 2012). Chlamydia suis is highly related to the human 
pathogen C. trachomatis (Everett et al. 1999). Therefore, C. suis is believed to have zoonotic 
potential. Interestingly, C. suis was recently detected in the eyes of Nepalese villagers 
suffering from trachoma (Dean et al. 2013), and in two healthy employees of a Belgian 
abattoir (De Puysseleyr et al. 2014a). However, the significance and clinical impact of C. suis 
infections in humans is still largely unknown. Therefore, the first aim of this study was to 
evaluate the presence of C. suis in pig farmers, on nine Belgian farms. Pigs and farmers were 
examined for the presence of C. suis DNA and viable C. suis bacteria. 
 
Chlamydial infections in livestock and humans are primarily treated with tetracycline (Tc), or 
one of its derivatives (Chopra and Roberts 2001; Michalova et al. 2004). Chlamydiaceae are 
generally highly sensitive to Tc, however, stably tetracycline resistant (Tc
R
) C. suis strains 
have been isolated in the U.S. in 1998, and since then also in Italy, Cyprus, Germany, Israel, 
Switzerland and Belgium, leading to treatment failure (Andersen 1998; Di Francesco et al. 
2008; Borel et al. 2012; Schautteet et al. 2012). The resistant phenotype is associated with the 
presence of a resistance gene tet(C) in the chlamydial chromosome (Dugan et al. 2004). The 
extensive in-feed use of Tc in commercial pig herds likely established a favorable 
environment for acquisition and maintenance of the tet(C) gene by C. suis (Dugan et al. 
2004). Emergence of Tc resistance in C. suis might also present a hazard to human health. 
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Suchland et al. (2009) demonstrated the in vitro transfer of the tet(C) gene among and within 
chlamydial species, including from C. suis into clinical isolates of C. trachomatis, resulting in 
a stable Tc
R
 phenotype. Given the possible zoonotic potential of C. suis, the transmission of 
Tc
R
 C. suis strains from pigs to C. trachomatis infected humans treated with Tc, would 
facilitate the transfer of Tc resistance into C. trachomatis. Once a resistant C. trachomatis 
strain is established, cross-serovar transmission through a patient population might occur 
rapidly (Suchland et al. 2009), leading to treatment failure in human medicine as well. This 
would affect millions of people worldwide suffering from ocular or genital C. trachomatis 
infections (WHO 2012). Therefore, we also examined the presence of the tet(C) gene in the 
identified porcine and human C. suis isolates on the Belgian farms. The identification of 
viable bacteria through isolation of chlamydial pathogens in cell culture remains crucial for 
the generation of new isolates and their characterization and pathogenesis studies. However, 
the reports on growth conditions of C. suis strains are limited, and isolation of C. suis from 
field samples is often fastidious (Sandoz and Rockey 2010). Hence, as second aim, the growth 
characteristics of a conjunctival, respiratory and intestinal C. suis strain were studied in cell 
culture. The growth of these strains was examined in six different cell lines, and two 
chlamydial growth media were compared. 
 
Tetracycline and its derivatives are critical therapeutic agents in the fight against chlamydial 
infections. However, the introduction and distribution of Tc resistance in C. suis creates a 
therapeutic challenge. New Tc analogs and antibiotics of other classes are frequently 
examined. Yet, resistance can evolve rapidly in microorganisms, further limiting treatment 
options. Therefore, alternative therapies are being investigated based on the inhibition of 
virulence rather than bacterial growth. This approach is considered to impose a lower 
selective pressure. Promising virulence blocking compounds have already been described. 
The third aim of this study was the evaluation of the anti-bacterial effect of two proteins 
towards extra- and intracellular C. suis bacteria in vitro. However, for reasons of 
confidentiality in view of valorization, the results of these experiments were not disclosed in 
this thesis. 
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Part of this chapter has been published as: 
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1 INTRODUCTION TO CHLAMYDIACEAE 
Chlamydiaceae are Gram-negative obligate intracellular bacteria causing disease in mammals 
and birds. Chlamydial bacteria show a unique biphasic life cycle characterized by two distinct 
morphological forms, the elementary bodies (EB) and the reticulate bodies (RB). These 
pathogens are widely spread and mainly replicate in macrophages, epithelial cells of the 
respiratory, gastrointestinal and urogenital tract, and in the conjunctiva (Pospischil et al. 
2010). Chlamydial infections in animals can lead to conjunctivitis, encephalomyelitis, 
respiratory disease, enteritis, arthritis, infertility, or abortion (Longbottom and Coulter 2003). 
Chlamydia (C.) trachomatis and C. pneumoniae are the most common chlamydial pathogens 
in humans, whereas the other species mainly infect other animals and birds. In the so-called 
developing countries, C. trachomatis is the leading cause of infectious blindness and sexually 
transmitted disease, which can induce pelvic inflammatory disease, infertility and ectopic 
pregnancy. Chlamydia pneumoniae causes respiratory disease, and chronic infections could 
contribute to atherosclerosis (Belland et al. 2004; Campbell and Kuo 2004). Several other 
chlamydial species may provoke zoonotic diseases, including C. psittaci (birds) and 
C. abortus (mainly in sheep and goats). Transmission of Chlamydiaceae occurs through direct 
contact or via aerosols without the need for an alternate vector (Everett 2000). 
2 TAXONOMY 
The taxonomy of the family of Chlamydiaceae (domain Bacteria, phylum Chlamydiae, class 
Chlamydiae) has been reclassified several times the last decades. Before 1999, the order of 
Chlamydiales only consisted of the family of Chlamydiaceae. In 1999, Everett et al. (1999) 
proposed a reclassification based on phylogenetic analyses of the 16S and 23S ribosomal 
RNA (rRNA) genes and genetic, phenotypic and morphological data. The family of 
Chlamydiaceae was divided into two genera, Chlamydia and Chlamydophila. The genus 
Chlamydia comprised the three species C. trachomatis, C. muridarum and C. suis. The genus 
Chlamydophila (Cp.) consisted of six species, Cp. psittaci, Cp. pneumoniae, Cp. abortus, 
Cp. pecorum, Cp. felis and Cp. caviae. Moreover, the order of the Chlamydiales was 
expanded with three additional families (Parachlamydiaceae, Simkaniaceae, Waddliaceae). 
However, comparative genomic analysis revealed that host-divergent strains of Chlamydiae 
are biologically and ecologically closely related and that the taxonomic separation of the 
Chlamydiaceae into two genera was inconsistent with the natural history of the organism. 
Therefore, the family of Chlamydiaceae is currently reunited into a single genus, Chlamydia, 
containing nine species (Table I-1) (Stephens et al. 2009). Recently, based on phylogenetic  
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Table I- 1 Members of the family Chlamydiaceae [according to Greub et al. (2010a; b) (adapted from Kerr et 
al. (2005))] 
Species Host Clinical signs 
Chlamydia trachomatis Humans Chronic conjunctivitis and blindness (trachoma) 
Sexually transmitted disease (STD)                   
Infection of the urogenital tract, infertility 
Chlamydia muridarum Mice          
Hamsters 
Respiratory tract infection                                    
Genital tract infection 
Chlamydia suis
 b
 Pigs Diarrhea, pneumonia, conjunctivitis, reproductive 
disorders 
Chlamydia pneumoniae Humans          
Koala 
Pneumonia, bronchitis, encephalomyelitis, laryngitis, 
atherosclerosis, reactive arthritis  
Chlamydia psittaci
 a
 Birds Respiratory tract infection 
Chlamydia gallinaceae
b
 Chicken       
Guinea fowl 
Turkey 
Respiratory tract infection 
Chlamydia avium
b
 Pigeons   
Psittacine birds 
Respiratory tract infection 
Chlamydia abortus
 a
 Ruminants         
Pigs 
Reproductive disorders, abortion and bad semen 
quality 
Chlamydia pecorum Ruminants       
Pigs               
Koala 
Reproductive disorders, infertility, infection of the 
urine tract (koala) and abortion, enteritis, polyarthritis, 
encephomyelitis, metritis, conjunctivitis and 
pneumonia (other animals) 
Chlamydia felis
 b
 Cats Conjunctivitis and respiratory tract infection 
Chlamydia caviae
 b 
Guinea pigs Ocular and urogenital tract infection 
a 
Zoonotic pathogen  
b
 Potential Zoonotic pathogen 
 
analysis of rRNA and ompA genes and multi-locus sequence analysis, two new species were 
added (Figure I-1). These species are referred to as C. avium sp. nov., consisting of strains 
originating from pigeons and psittacine birds, and C. gallinacea sp. nov., comprising of 
strains from poultry (Sachse et al. 2014b). 
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Figure I-1 Phylogenetic reconstruction of the Chlamydiaceae classification, including the two new 
species Chlamydia avium and Chlamydia gallinaceae based on the alignment of almost complete 16S 
rRNA genes. The numbers on the nodes indicate the bootstrap support of each branch after 100 
replicates. The bar indicates 1% sequence divergence. Adapted from Sachse et al. (2014a). 
 
3 MORPHOLOGY 
3.1 Developmental forms 
Chlamydiaceae possess a unique biphasic developmental cycle during which two 
morphologically distinct structures can be observed, the infectious elementary body (EB) and 
the replicating reticulate body (RB). An overview of the most important discriminative 
characteristics is represented in table I-2. Elementary bodies are usually small (0.2-0.3 µm), 
spherical, electron dense structures with a dense eccentric core of condensed DNA and 
chromatin (Costerton et al. 1976; Longbottom and Coulter 2003). They are surrounded by a 
lipid cytoplasmic membrane and a rigid outer membrane (both ~8 nm) with extensive 
disulfide bridging between cysteine and methionine residues of outer membrane proteins, 
including the ‘Major Outer Membrane Protein’ (MOMP) (Newhall and Jones 1983). 
Therefore, EBs are osmotically more stable and less permeable than RBs, allowing them to 
survive up to several months outside the host cell (Longbottom and Coulter 2003). 
Elementary bodies are metabolically inert until attachment to the host cell and subsequent 
internalization. 
Upon uptake by the host cell, the elementary bodies differentiate into non-infectious 
replicating reticulate bodies. During this transition, disulphide bonds between outer 
membrane proteins are reduced, rendering the outer membrane more permeable to facilitate 
nutrient uptake by the RBs (Newhall and Jones 1983). Compared to EBs, RBs are also 
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spherical but have a larger diameter (0.5-1.6 µm). Their cytoplasm is less electron dense and 
the nucleus is not clearly distinguishable. The RBs become transcriptionally more active, 
leading to higher amounts of RNA and ribosomes in the cytoplasm, required for protein 
synthesis (Ward 1988). Reticulate bodies are metabolically active and replicate intracellularly 
by binary fission. During maturation from RBs back to EBs, morphologically intermediate 
bodies (IBs) can be formed, which are capable of infecting host cells in vitro (Litwin et al. 
1961; Costerton et al. 1976; Vanrompay et al. 1996; Rockey and Matsumoto 2000). 
 
Table I-2 Characteristics of chlamydial elementary and reticulate bodies. 
 
 
 
 
 
 
 
 
 
 
 
3.2 Outer membrane composition 
Similar to other Gram-negative bacteria, Chlamydiaceae are surrounded by two membranes, a 
cytoplasmic inner membrane and an outer membrane, separated by a periplasmic space. The 
outer membrane of EBs consists of phospholipids, lipids, lipopolysaccharides and proteins. A 
substantial part of the chlamydial cell wall is insoluble in the ionic detergent sarcosyl, which 
usually indicates the presence of peptidoglycans covalently linked to lipoproteins. Indeed, 
genes for peptidoglycan synthesis are present in the genome. However, only negligible 
amounts of peptidoglycans are present in the cell wall of Chlamydiaceae, and yet they are 
sensitive to antibiotics targeting peptidoglycan synthesis, such as penicillin. This 
contradiction is known as the ‘chlamydial anomaly’. The cell wall fraction insoluble in 
sarcosyl is referred to as the ‘Chlamydia Outer Membrane Complex’ (COMC) or cell 
envelope, mainly consisting of MOMP, the cysteine rich proteins (CRP) Omp2 and Omp3, 
Characteristic Elementary body Reticulate body 
Morphology Spherical Spherical 
Diameter 0.2-0.3 µm 0.5-1.6 µm 
Electron density High Low 
Cell wall Rigid, cross-linked Permeable, fragile 
Infectivity for the host High None 
RNA/DNA ratio 1:1 3:1 (more ribosomes) 
Metabolic activity Relatively inactive Active, binary fission 
Trypsin digestion Resistant Sensitive 
Projections (T3SSs) 11-20, small patch Up to 83, larger patch 
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and the polymorphic membrane proteins (pmps) (Figure I-2). Furthermore, 
lipopolysaccharides, PorB, Omp85, heat shock proteins hsp60 and hsp70, and OprB are 
present in the outer membrane. The most important components will be further discussed in 
detail below. 
 
 
Figure I-2 Schematic representation of the chlamydial EB double membrane. In the outer membrane, 
MOMP, both CRPs and the pmps are represented. Adapted from Hatch et al. (1996). 
 
3.2.1 Major outer membrane protein 
The cysteine rich MOMP protein, encoded by the ompA gene, has a molecular weight of ~40 
kDa and is always present as a trimer. It accounts for about 60% of the outer membrane 
protein mass of EBs, and nearly 100% of RBs (Caldwell et al. 1981). Following reduction of 
disulphide bonds during the EB to RB transition, MOMP can function as a porin, allowing 
nutrient uptake by the RB. Moreover, MOMP is presumed to function as an adhesion, 
involved in nonspecific (electrostatic and hydrophobic) interactions with the host cell (Su et 
al. 1990). The MOMP protein contains four variable domains (VD1-VD4), localized at the 
outside of the bacterial membrane, flanked by highly conserved hydrophobic regions (Baehr 
et al. 1988a; Yuan et al. 1989) (Figure I-3). The variabele domains of MOMP enclose family, 
genus, species, subspecies and serovar specific epitopes (Caldwell et al. 1981; Yuan et al. 
1989; Everett 2000; Kim and DeMars 2001b). Furthermore, MOMP is an immunodominant 
protein, and mono- and polyclonal antibodies against MOMP have been shown to neutralize 
Chlamydiaceae infections in vitro and in vivo (Caldwell and Perry 1982; Zhang et al. 1987). 
Outer
membrane
Periplasm
Inner
membrane
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Figure I-3 Model of the positioning of the MOMP protein in the outer membrane of the chlamydial cell 
wall. The conserved regions are represented as full lines and localized inside the outer membrane. The 
alternating lines represent the surface-exposed variable domains I to IV [adapted from (Baehr et al. 1988b) (Kim 
and DeMars 2001a)]. 
 
3.2.2 Cysteine rich proteins 
Two cystein rich proteins (CRP), Outer membrane protein 2 (Omp2, OmcB or EnvB) and 3 
(Omp3, OmcA or EnvA) are the second most important proteins present in the COMC. These 
proteins are highly abundant in EBs, but not in RBs. The omp proteins are expressed late in 
the growth cycle, when RBs redifferentiate into EBs. Outer membrane protein 2 has a 
molecular weight of ~60 kDa, is highly conserved, and has been shown to function as an 
adhesin in C. trachomatis LGV1 (Stephens et al. 2001; Fadel and Eley 2007; 2008). Since 
this protein is Chlamydiaceae specific and highly immunogenic, it can be used as marker for 
chlamydial infections (Sanchez-Campillo et al. 1999). The omp3 lipoprotein is the smaller 
CRP with a molecular weight ranging from 9 kDa in C. trachomatis to 12 kDa in C. psittaci 
(Everett and Hatch 1995). The omp3 gene sequence is less conserved within the 
Chlamydiaceae, compared to omp2 (Everett and Hatch 1991). 
 
3.2.3 Polymorphic membrane proteins 
Longbottom et al. (1996) first discovered the pmps at the surface of C. abortus S26/3. The 
number of pmp genes present is variable between species, ranging from 9 pmp genes in 
C. trachomatis to 21 in C. pneumoniae, as genome sequencing revealed (Stephens et al. 1998; 
Kalman et al. 1999). The pmps represent 3 to 5% of the genome, however, their function has 
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currently not been fully elucidated. Homology searches, structural comparisons and amino 
acid sequence analysis strongly suggest that the pmps belong to the family of 
autotransporters. Based on phylogenetic analysis, pmps fall into six subtypes, implying at 
least six different roles, probably also including virulence (Henderson and Lam 2001). For 
some pmps, specific roles in pathogenesis have already been demonstrated, such as adhesion 
mediated by GGAI motif repeats (Grimwood and Stephens 1999; Kalman et al. 1999; Read et 
al. 2000; Wehrl et al. 2004; Molleken et al. 2010). 
3.2.4 Other outer membrane proteins 
The PorB (or OmpB) protein has a molecular weight of 37 kDa and is present in the outer 
membrane. This protein is rich in cysteine residues and highly conserved among chlamydial 
strains, yet, expressed in low amounts. PorB probably functions as a substrate-specific porin, 
transferring dicarboxylic acids, and might thus compensate for the incomplete tricarboxylic 
acid cycle (Iliffe-Lee and McClarty 2000). PorB-specific antibodies have shown to possess 
neutralizing activity (Sanchez-Campillo et al. 1999). 
Omp85 is a highly conserved outer membrane protein, widely present in various Gram-
negative bacteria. This protein is involved in the insertion and positioning of lipids and 
proteins into the outer membrane (Genevrois et al. 2003), and Omp85 specific antibodies can 
neutralize chlamydial infections, at least in vitro (Stephens and Lammel 2001). 
The chlamydial lipopolysaccharide (LPS) has a molecular weight of 10 kDa, is present on 
both EBs and RBs, and is highly antigenic. It has a lipid A part, with two glucosamines 
(GlcN) bound to fatty acids. Moreover, it contains a specific tri-saccharide of 3-deoxy-D-
manno-oct-2-ulopyranosonic acids (Kdo) of which two residues are linked through a 2→8 
linkage, which is unique for Chlamydiaceae (Brade et al. 1987). 
The COMC of EBs and RBs also includes heat shock proteins (Hsps). These proteins are 
highly conserved within chlamydial species, and are believed to play an important role in 
chlamydial immunopathology (Zhong and Brunham 1992). The currently identified 
chlamydial Hsps include Hsp10 (GroES), Hsp60 and Hsp70 (Kornak et al. 1991; Brunham 
and Peeling 1994), which are homologues to GroEL (Hsp60) and DnaK (Hsp70) of 
Escherichia (E.) coli and human mitochondria, with up to 50% protein sequence identity 
(Brunham and Peeling 1994). 
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4 DEVELOPMENTAL CYCLE 
As obligate intracellular bacteria, Chlamydiaceae display a unique biphasic life cycle. An 
overview of the different stages of chlamydial replication is represented in figure I-4. The 
acute infection of a host cell initiates with the attachment of EBs to the eukaryotic cell and the 
subsequent uptake into endocytic vesicles, referred to as inclusions (1 and 2). The EBs tend to 
attach near microvilli, on the apical surface of the host cell. Since these membrane regions 
actively transport extracellular material into the host cell, attachment at the base of the 
microvilli might facilitate entry into the host cell (Escalante-Ochoa et al. 1998). Furthermore, 
attachment might also be associated with clathrin-coated pits, as observed for C. psittaci EBs 
(Vanrompay et al. 1996). Several conflicting mechanisms have been described, which 
possibly occur independently from each other (Byrne and Moulder 1978). Still, the exact 
mechanism of attachment and entry remains unresolved. Following uptake, the inclusions 
efficiently avoid lysosomal fusion. For some species, such as C. trachomatis, distinct 
vacuoles can fuse into a larger inclusion (Ridderhof and Barnes 1989; Hackstadt et al. 1999), 
while for other species, including C. pneumoniae and C. psittaci, fusion of inclusions has not 
been observed (Rockey et al. 1996; Vanrompay et al. 1996). The EBs differentiate into RBs, 
starting from 2 h post infection (p.i.) (3). These RBs migrate to the inclusion periphery, and 
start to replicate by binary fission, from 8 h p.i. on (4). During this replication phase, host 
plasma proteins, and lipids and sphingomyelins, acquired from Golgi-derived vesicles, are 
incorporated into the inclusion membrane, leading to an increase in the inclusion surface 
(Hackstadt et al. 1996; Scidmore et al. 1996) (5). Furthermore, also inclusion membrane 
proteins (Incs) are inserted into the inclusion membrane (Rockey et al. 2002). Late in the 
developmental cycle, RBs detach from the inclusion membrane and re-differentiate into EBs, 
stored in the lumen of the inclusion. Finally, EBs and remaining non-differentiated RBs are 
released from the host cell through lysis or reverse endocytosis (6). This release regularly 
occurs at 24 to 72 h p.i., depending on the host cell and chlamydial species. However, 
deviations of the replication cycle can be observed, at least in vitro. In some cases, chlamydial 
organisms are present within a host cell, but the life cycle seems interrupted and no visible 
growth can be observed (7). This phenomenon is known as persistence, and can be induced by 
several factors, including antibiotics, nutrient deprivation or immune factors, such as 
interferon gamma (IFN-ɤ) (Mpiga and Ravaoarinoro 2006). During this persistent state, 
relatively small inclusions and enlarged pleiotrophic RBs or persistent bodies (PBs) are 
formed (Hogan et al. 2004). The PBs accumulate chromosomes, but expression of genes for 
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cell division does no longer occur (Byrne et al. 2001). Persistent bodies revert to normal RBs 
upon removal of the stress-inducing factor, and the developmental cycle is completed. The 
role and significance of persistence in vivo, and the involvement in chronic infections remains 
elusive. The major developmental phases will be further discussed below. 
 
Figure I-4 Schematic overview of the developmental cycle of Chlamydiaceae. Bacteria attach preferentially at 
the base of microvilli and then enter the host cell through parasite specific endocytosis (1). Within the thus 
formed inclusion, avoiding fusion with host cell lysosomes (2), EBs transform into RBs (3). RBs proliferate at 
the boundaries of the inclusion by binary fission, until detachment from the inclusion membrane (4-5). RBs 
revert back to EBs and are stored in the lumen of the inclusion until liberation through lysis or reverse 
endocytosis (6). 
1 2 
3 
4 5 
6 
7 
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4.1 Attachment: glycosaminoglycans, adhesins and host cell receptors 
The attachment of EBs to the host cell probably occurs in at least two steps (Figure I-5). First, 
EBs attach through a reversible electrostatic interaction with heparin sulphate-like 
glycosaminoglycans (GAGs) of host origin (Zhang and Stephens 1992; Su et al. 1996; Davis 
and Wyrick 1997). This reversible interaction is followed by a second, irreversible binding of 
a chlamydial ligand to an unknown host cell receptor, inducing internalization (Carabeo and 
Hackstadt 2001; Fudyk et al. 2002). Since the effect of GAG on the attachment and infectivity 
varies among Chlamydiaceae species, both GAG-dependent and independent mechanisms are 
likely involved in the attachment process (Zhang and Stephens 1992; Su et al. 1996; 
Rasmussen-Lathrop et al. 2000; Fadel 2004). The exact nature of the host cell receptors and 
chlamydial ligands has not been completely defined. However, several possible bacterial 
ligands have been identified, including MOMP (Su et al. 1990), Hsp70 (Raulston et al. 1993), 
OmcB (Ting et al. 1995; Moelleken and Hegemann 2008), the pmp proteins (Wehrl et al. 
2004; Crane et al. 2006; Moelleken and Hegemann 2008), and chlamydial type three secretion 
system (T3SS) translocon components (CopB, CopD and LcrV) (Watarai et al. 1996; Skoudy 
et al. 2000). 
 
Figure I-5 Attachment and entry of chlamydial EBs. Chlamydiaceae interact with the host cell through 
reversible electrostatic interaction with heparin sulphate-like GAGs on the cell surface, followed by an 
irreversible interaction with unidentified host cell receptors, possibly associated with cholesterol-rich lipid raft 
microdomains. Next, host specific signal transduction pathways mediate internalization of the bacteria by actin 
recruitment and pedestal formation, possibly after injection of T3SS effector proteins (e.g. Tarp). Infection leads 
to rapid phosphorylation of host cell proteins. Image reproduced from (Dautry-Varsat et al. 2005). 
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4.2 Internalization 
Electron microscopy studies revealed two major possible mechanisms for chlamydial entry 
into the host cell: zipper-like microfilament dependent phagocytosis (Byrne and Moulder 
1978) and clathrin-mediated endocytosis (Hodinka et al. 1988). Zipper-like microfilament 
dependent phagocytosis is induced by binding of chlamydial adhesins to host cell receptors. 
This entry probably occurs via cholesterol-rich lipid raft domains, which are highly connected 
to the actin cytoskeleton (Stuart et al. 2003; Lillemeier et al. 2006). Lipid rafts function as 
signaling platforms (Simons and Toomre 2000) involved in endocytosis (Parton and Richards 
2003), intracellular vesicle trafficking (Helms and Zurzolo 2004), and activation of immune 
response and apoptosis (Gombos et al. 2006). Lipid raft-mediated entry leads to a remodeling 
of the actin skeleton and the derived endosomes do not enter the lysosomal degradation 
pathway (Helms and Zurzolo 2004), two features resembling the chlamydial developmental 
cycle. The exact mechanism of chlamydial internalization through lipid rafts remains elusive, 
but might be as proposed in figure I-5. 
For some chlamydial species, including C. trachomatis and C. psittaci, association to clathrin-
coated pits and uptake into clathrin-coated vesicles has been observed, suggesting entry 
through receptor-mediated endocytosis (Reynolds and Pearce 1990). However, the occurrence 
of this type of entry appeared to be dependent upon the inoculation route and culture 
conditions (Prain and Pearce 1989; Wyrick et al. 1989; Reynolds and Pearce 1990). The 
importance of clathrin-mediated endocytosis for chlamydial entry into the host cell is 
currently not fully clarified (Balana et al. 2005; Dautry-Varsat et al. 2005). 
Only minutes after chlamydial attachment, actin is recruited to the entry site, albeit 
transiently, forming an actin-rich pedestal underneath the attachment site. Consequently, the 
EBs are internalized by the host cell into membrane-bound vesicles, as demonstrated for 
C. trachomatis (Carabeo et al. 2002), C. pneumoniae (Coombes and Mahony 2002), 
C. psittaci (Beeckman et al. 2007), and C. caviae (Subtil et al. 2004). Clifton et al. (2004) 
identified the translocated actin-recruiting phosphoprotein, also called ‘Tarp’, to be involved 
in this process. Chlamydiae use their T3SS to translocate Tarp into the cytoplasm of the host 
cell, thus inducing actin recruitment to the invasion site. Tarp orthologs were already 
identified for all current pathogenic Chlamydiaceae species. Distinct functional domains have 
been identified into the N- and C-terminal regions of C. trachomatis Tarp. The N-terminal 
region contains tyrosine-rich tandem repeats, phosphorylated inside the host cell, and hereby 
interacting with guanosine nucleotide exchange factors and small GTPases (Lane et al. 2008). 
In this way, a signal transduction cascade is initiated. However, some species, such as 
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C. abortus and C. psittaci, lack the repeat domain in their Tarp sequence. Accordingly, no 
tyrosine phosphorylation of Tarp is required to initiate actin recruitment in these species. 
Meanwhile, the C-terminal part contains a proline-rich domain, promoting Tarp 
oligomerization, and an actin binding domain (Jewett et al. 2006). Both domains are required 
for Tarp-dependent nucleation of new actin filaments, and are conserved among chlamydial 
species. 
Other chlamydial actin recruitment and entry pathways have already been suggested. 
Swanson et al. (2007) identified the 70-kDa host protein ezrin, a member of the ezrin-radixin-
moesin protein family, acting as a physical link between host cell receptors and the actin 
cytoskeleton. Ezrin colocalizes with actin at the chlamydial attachment and entry sites. 
Although initial ezrin activation through threonine phophorylation is common among 
Chlamydiae, subsequent tyrosine phosphorylation was only demonstrated for infection of host 
cells with C. trachomatis strains. This might imply species-specificity of chlamydial entry 
pathways, involving chlamydial specific ligands and host cell receptors. Ezrin is known to 
interact with the cytoplasmic domain of several receptors, including CD44, member of the 
integrin superfamily and intercellular adhesion molecules. Other possible ligands identified as 
chlamydial adhesins include T3SS translocon components, such as CopB, CopD and LcrV, as 
mentioned earlier. Conclusively, Chlamydiaceae probably enter their host cell through more 
than one pathway, which might be species specific, but possibly partially overlap. 
 
4.3 Inhibition of the phagolysosomal fusion 
Chlamydiaceae can efficiently impede fusion of the inclusion to lysosomes, thus preventing 
subsequent eradication. This ability is exclusively restricted to Chlamydia-containing 
inclusion vacuoles (Eissenberg and Wyrick 1981). However, not all inclusions can escape 
phagolysosomal fusion, depending on the host cell, chlamydial strain and mode of entry 
(Moulder 1991). The inclusion membrane has a unique composition, since markers of the 
plasma cell membrane, early or late endosomes, or lysosomes, such as the vacuolar 
H
+
 ATPase, are absent (Heinzen et al. 1996; Scidmore et al. 1996; Taraska et al. 1996; Al-
Younes et al. 1999). In accordance with the absence of vacuolar H
+
 ATPase, no acidification 
of the inclusion lumen can be observed. Interestingly, EB-containing vesicles only slowly 
acquire lysosomal characteristics upon blocking of protein synthesis. A dual mechanism for 
prevention of the phagolysosomal fusion has been proposed, consisting of an initial phase of 
delayed maturation depending on an intrinsic property of EBs, followed by an active 
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modification of the inclusion membrane, wherefore chlamydial synthesis of proteins, such as 
chlamydial Incs, is demanded (Scidmore et al. 2003). The required intrinsic property of EBs 
might be the translocation of previously produced type three secretion (T3S) effector proteins, 
as was observed in Salmonella (Hackstadt et al. 1997; Wyrick 2000). As noted earlier, lipid 
raft-derived endosomes do not enter the lysosomal degradation pathway. Correspondingly, 
certain bacteria, such as Mycobacterium spp., are protected against phagolysosomal fusion (de 
Chastellier and Thilo 2006). Therefore, the underlying chlamydial mechanism for prevention 
of lysosomal degradation might be similar. 
4.4 Proliferation 
The RBs, migrated to the periphery of the inclusion, initiate division through binary fission, 
starting 8 h p.i. Generally, the filamentation temperature sensitive (ftsZ) protein plays a key 
role in bacterial cell division. Hence, it is highly conserved among eubacteria. However, 
Chlamydiae lack an identifiable ftsZ ortholog. Nevertheless, other factors have been identified 
possibly substituting for the lack of FtsZ during the formation of division septa. As noted 
earlier, RBs synthesize small amounts of peptidoglycan, in which the chlamydial MurA 
ortholog (UDP-N-acetylglucosamine enolpyruvyl transferase) catalyzes the first step (Chopra 
et al. 1998). The murA gene is expressed during EB to RB differentiation and replication, and 
the chlamydial murA ortholog appeared to be functional in murA deficient E. coli. Hence, 
peptidoglycans might be involved in chlamydial replication (McCoy and Maurelli 2006). 
Moreover, the SEP (septum) antigen was observed to localize as a ring-like structure beside 
the chlamydial division plane, resembling the distribution of FtsZ at the septum during 
bacterial cell division. This localization was only observed in actively dividing RBs and thus 
may be associated with RB replication (Brown and Rockey 2000). The RBs undergo multiple 
rounds of division through binary fission, until contact to the inclusion membrane through 
their T3SS is lost (Wilson et al. 2006). Then, the RBs detach from the inclusion membrane 
and redifferentiate asynchronously into EBs, that are stored in the inclusion lumen until 
release.  
4.5 Nucleotide acquisition 
Multiple findings in literature indicate that Chlamydiaceae behave as ‘energy parasites’. They 
absorb a large amount of nutrients from the host cytosol throughout their obligate intracellular 
lifecycle, eliminating the need for their own de novo production. Moreover, they do not 
exhibit de novo nucleotide synthesis and show a restricted nucleotide metabolism and lower 
ability of ATP generation. However, genome sequencing revealed that Chlamydiae do possess 
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genes allowing production of their own ATP, probably by both the glycolytic pathway and 
their truncated tricarboxylic acid cycle (Iliffe-Lee and McClarty 1999). Therefore, 
Chlamydiae may not be strict auxotrophic. 
To withdraw energy molecules from the host, Chlamydiaceae possess nucleotide transport 
proteins (NTTs). This enables them to perform ATP-ADP counter-exchange and to import 
nucleotides. The genome of C. trachomatis, for instance, contains two genes coding for 
nucleoside phosphate transporters 1 and 2 (Npt1Ct and Npt2Ct), each performing a different 
type of transport (Tjaden et al. 1999). First, Npt1Ct is an ATP-ADP exchanger, able to 
function in ATP acquisition from the host cytosol. Secondly, Npt2Ct catalyses transport of 
nucleotides and H
+
 into the cell. Likewise, C. pneumoniae (Kalman et al. 1999) and 
C. psittaci exhibit an ATP-ADP exchange (Hatch et al. 1982). The ribonucleoside 
triphosphate/H+ transporters of other Chlamydia spp. may be of distinct specificity. 
Gene expression studies revealed that strong upregulation of the ATP/ADP anti-porter gene of 
C. trachomatis occurs early in the developmental life cycle. Indeed, uptake of ATP from the 
host cell would be most relevant early in the infection process, when the whole complement 
of enzymes for ATP generation via glycolytic and pentose pathway is not present yet, such as 
during initial differentiation of EBs to RBs shortly after infection of the host cell. Moreover, 
the substrate for oxidative phosphorylation is now limited in the host cytosol. Under these 
circumstances, an alternative way for energy generation is an advantage. Later on, only after 
inclusion niche establishment, structural proteins and proteins of intermediary metabolism are 
expressed. Once cell division starts, the energy need rises and available energy generation 
increases by the glycolytic and pentose pathways (Shaw et al. 2000). Although Chlamydia 
can transport ATP across the bacterial membrane, the mechanism through which the highly 
charged ATP molecules pass the inclusion membrane to reach the bacteria is unknown so far, 
as pores for passive diffusion are absent (Heinzen and Hackstadt 1997). 
4.6 Type III secretion 
The chlamydial T3SS participates in multiple steps of the chlamydial infection process. At the 
very start of infection, T3S translocon components might be involved in the irreversible 
attachment, as mentioned above. The CopB protein likely functions as an adhesin, binding the 
hyaluron receptor CD44 in lipid rafts, thus inducing assembly of the T3SS translocon in the 
eukaryotic membrane. In addition, surface exposed T3SS components, such as the outer 
membrane secretin SctC or needle protein SctF, might also function as ligands in receptor-
mediated uptake of Chlamydiae (Beeckman and Vanrompay 2010). Shortly after attachment, 
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the T3SS translocates the effector protein (T3SE) Tarp into the host cytosol, leading to actin 
recruitment at the attachment site. A pedestal-like structure is formed beneath the attached 
EB, followed by internalization. In addition to two already identified underlying signaling 
cascades, other currently uncharacterized T3SEs are likely implicated in additional signaling 
pathways involved in EB uptake (Jewett et al. 2006; Lane et al. 2008). Once an inclusion 
vacuole is established, the inclusion membrane is actively modified through insertion of 
inclusion membrane proteins or Incs, such as CT229 or IncA, probably through T3S. Multiple 
functions have been assigned to the Inc proteins, including avoidance of phagolysosomal 
fusion, and diverting intracellular host cell trafficking to the nascent inclusion to acquire 
nutrients (Rzomp et al. 2006; Cortes et al. 2007; Delevoye et al. 2008). Other T3SEs, such as 
the Chlamydia protein associating with death domains (CADD), could be involved in host cell 
reprogramming and modulation of apoptosis. The CADD protein likely acts through binding 
to the death domains of tumor necrosis factor receptor (Stenner-Liewen et al. 2002). Later in 
the infection cycle, during proliferation, RBs are closely attached to the inclusion membrane, 
in which the T3SS is also involved. Near the end of the infection cycle, RBs detach from the 
inclusion membrane due to spatial limitations in the host cell, inactivating the T3SS and 
inducing asynchronous re-differentiation of RBs into EBs (Wilson et al. 2006; Peters et al. 
2007). 
4.7 Regulation of virulence gene expression - Quorum sensing 
Quorum sensing (QS) is a bacterial system involved in the regulation of gene expression in 
response to environmental cues, such as cell-population density (Miller and Bassler 2001). 
Though the concept of QS is common among bacteria, the exact molecular mechanism may 
differ among species. At least six different QS pathways are identified so far (Table I-3) 
(Surette et al. 1999; Schauder et al. 2001; Chen et al. 2002; Sperandio et al. 2003; Henke and 
Bassler 2004; Higgins et al. 2007; Kendall et al. 2007). A common signaling pathway 
containing the membrane-bound QseC histidine sensor kinase (Clarke et al. 2006) or its 
homologues, is present in more than 25 important pathogens in humans and plants. QseC 
perceives the bacterial quorum sensing signal autoinducer 3 (AI-3) and/or host derived 
adrenalin and/or noradrenalin. After binding of the signal, QseC increases its 
autophosphorylation. The following phosphorylation cascade in the bacterial cell regulates the 
expression of virulence genes (Sperandio et al. 2003; Hughes and Sperandio 2008). 
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Table I-3 Quorum sensing pathways in Bacteria. 
 
The genome of C. trachomatis comprises two genes, ctcB and ctcC, with protein sequence 
similarity to histidine kinase-response regulator pairs of two-component systems (Figure I-6). 
The latter are a type of QS pathway, which play a role in stage-specific gene expression, such 
as in- and outside the host cell, two completely different environments in the Chlamydiaceae 
biphasic life cycle. Generally, the histidine sensor kinase component in the bacterial 
membrane autophosphorylates upon signal perception and subsequently phosphorylates and 
activates a response regulator, usually a transcription factor, which binds to the promoter of a 
target gene and initiates transcription upon activation. The sensor kinase and response 
regulator pair form a genetic network together with a range of downstream molecular factors. 
This network controls a specific subset of genes, including virulence genes (Novick 2003; 
Lyon and Novick 2004). 
Two-component systems are a primary mechanism to adapt to environmental conditions. 
Though little is known about transcriptional regulation in Chlamydiae, gene expression and 
development are most likely controlled through recognition of environmental cues or 
intracellular conditions. Although many bacteria possess several systems to adapt to diverse 
environmental changes, this is the only complete two-component system identified in 
C. trachomatis. Moreover, this ctcB-ctcC system proved to be functional as it is capable of 
autophosphorylation and phosphotransfer reactions (Koo and Stephens 2003). 
 
Pathway Signal molecules Bacteria References 
AHL (AI-1 pathway)
 
AHLs Gram-negative 
(Salmond et al., 1995, Ravn et 
al., 2001, Zavilgelsky and 
Manukhov, 2001) 
4Qs pathway
 
PQS and HHL Gram-negative (Diggle et al., 2006) 
AI-3 pathway
 
AI-3 Gram-negative 
(Sperandio et al., 2003, Kendall 
et al., 2007) 
AI-2 pathway
 
Two different forms 
Gram-negative and 
Gram-positive 
(Surette et al., 1999, Schauder 
et al., 2001, Chen et al., 2002) 
AIP pathway
 
Oligopeptides Gram-positive (McDowell et al., 2001) 
CAI-1
 
hydroyketones Gram-negative 
(Henke and Bassler, 2004, 
Higgins et al., 2007) 
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The CtcB and CtcC genes possess a late expression profile and, accordingly, the 
corresponding proteins are present in EBs, but not in RBs (Koo and Stephens 2003). Most 
two-component system components, however, are constitutively expressed to adapt efficiently 
to a changing environment. The late expression profile thus implies involvement in the 
control of a subset of late genes participating in RB to EB transition. Moreover, the sensor 
kinase CtcB possesses a redox sensing domain (Koo and Stephens 2003). This could sense the 
change in redox state when EBs enter the host cells and disulfide-linkage in the outer 
membrane proteins are reduced, which results in a higher membrane flexibility and increased 
nutrient uptake. Similarly, a decrease in energy sources or reducing agents results in oxidation 
of sulfhydrylgroups, hindering RB development and decelerating metabolic activity (Bavoil et 
al. 1984; Hackstadt et al. 1985; Ward 1988). To conclude, CtcB and CtcC are 
developmentally late-expressed proteins with a redox sensing domain. This domain is most 
likely involved in late gene activation, including the regulation of RBs to EBs differentiation. 
 
  
Figure I-6 Organization of the prototypical Two-
Component Signal Transduction System (TCSS) in 
bacteria. The prototypical TCSS is comprised of a single 
sensor kinase (SK) and a single response regulator (RR). The 
input domain of the SK recognizes a specific signal(s) from 
the environment. This recognition results in activation of the 
kinase domain and autophosphorylation in the output domain 
of the SK at a conserved histidine residue. The output domain 
of the phosphorylated SK interacts with the receiver domain 
of the RR, catalyzing the transfer of phosphate to a conserved 
aspartate residue within the receiver domain. Phosphorylation 
of the RR activates its output domain, resulting in 
conformational changes in the RR that mediate specific 
biological activities, including DNA binding and 
transcriptional regulation (adapted from (Mitrophanov and 
Groisman 2008)). 
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5 CHLAMYDIACEAE INFECTIONS IN PIGS 
5.1 Chlamydiaceae in pigs 
Currently, four chlamydial species have been isolated from pigs: C. psittaci, C. pecorum, 
C. abortus and C. suis. These four species are briefly described below. 
Chlamydia psittaci is widely known as an avian pathogen, infecting the conjunctiva, gastro-
intestinal and respiratory tract in birds. These infections regularly result in systemic disease, 
which can be inapparent to severe, and acute or chronic. Transmission of C. psittaci among 
birds mainly occurs through inhalation of contaminated aerosols, but also vertical 
transmission through the egg is possible (Busch et al. 2000; Vanrompay et al. 2004). 
Moreover, C. psittaci is transmissible from birds to humans, and even human-to-human 
transmission has been reported. The clinical signs of human infections can vary widely, from 
mild flu-like symptoms to severe pneumonia (Beeckman and Vanrompay 2009). Furthermore, 
C. psittaci has been isolated from lung and genital tract tissue of pigs. The reference strain for 
C. psittaci is 6BC
T 
(=ATCC VR 125
T
). 
Chlamydia pecorum strains are serologically and pathogenically highly diverse. This species 
has been isolated from various mammal hosts, including ruminants (cattle, sheep and 
goats)(Fukushi and Hirai 1992), koalas (Girjes et al. 1993) and pigs (Kaltenboeck and Storz 
1992). In koalas, C. pecorum infections cause urinary tract disease, reproductive disease, and 
infertility. In other mammals, this species causes conjunctivitis, encephalomyelitis, 
pneumonia, enteritis, abortion, and polyarthritis. The type strain is C. pecorum E58
T
 (=ATCC 
VR 628
T
). 
Chlamydia abortus is the most frequent cause of abortion in sheep and goats in Europe, also 
known as ovine enzootic abortion (OEA), leading to major economic loss in agriculture (Kerr 
et al. 2005). Chlamydia abortus is endemic among ruminants, where it efficiently colonizes 
the placenta. Moreover, reproductive failure due to C. abortus infections has been described 
in cattle, horses, pigs, deer and mice (Everett et al. 1999; Longbottom and Coulter 2003). 
Zoonotic C. abortus infections have been reported, leading to miscarriages and stillbirths in 
farm women working with sheep (Johnson et al. 1985; Wong et al. 1985) and goats 
(Pospischil et al. 2002; Meijer et al. 2004). The type strain is C. abortus B577
T
 (= ATCC VR 
656
T
). 
Chlamydia suis is considered as endemic in the intestinal flora of pigs, which are considered 
the only natural hosts for C. suis (Schautteet and Vanrompay 2011). Among Chlamydiae 
occurring in pigs, C. suis is most frequently detected. Infections can remain asymptomatic, or 
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be associated with conjunctivitis, enteritis, pneumonia, and reproductive disorders. Its primary 
pathogenicity was proven in multiple experimental infections in gnotobiotic pigs (Rogers and 
Andersen 1996; 1999; 2000; Reinhold et al. 2008; Reinhold et al. 2010; De Clercq et al. 
2014). Resistance to sulfadiazine and/or Tc has been demonstrated in several strains. 
Sequence analysis suggest a genetically high diversity among C. suis strains, compared to 
other chlamydial species (Everett et al. 1999). The reference strain is C. suis S45
T
 (ATCC VR 
1474
T
). 
5.2 Epidemiology 
5.2.1 Serodiagnosis 
The seroprevalence of Chlamydiaceae has been widely reported in Europe. However, the 
available serodiagnostic tests are based on detection of family specific antibodies, and thus 
are not able to assess the occurrence of individual species. Nevertheless, the prevalence of 
Chlamydiaceae infections proved to be high. The earliest serological data on the occurrence 
of chlamydial infections date back to 1966, when Wilson and Plummer (1966) demonstrated 
antibodies against Chlamydiaceae in 23% of sera of pigs in Great Britain. Vanrompay et al. 
(2004) examined 258 Belgian pig farms, and reported a Chlamydiaceae seroprevalence of 
97%. According to Eggeman et al. (2000a), 33% to 72% of the sows and 10 to 47% of the 
boars in Germany produced Chlamydiaceae-specific antibodies. In Switzerland, 
seroprevalence rates of 62% for sows, 7% for piglets younger than four weeks and 48% for 
piglets older than four weeks were reported (Camenisch et al. 2004b). Moreover, 83% of the 
tested Swiss finisher pigs were seropositive for Chlamydiaceae (Szeredi et al. 1996). 
Similarly, seroprevalence rates were 64 to 81% in Italian finisher pigs (Di Francesco et al. 
2006). Of interest, Chlamydiaceae-specific antibodies were demonstrated in 64% of Italian, 
free-living boars, suggesting a Chlamydia reservoir in wild boar populations (Di Francesco et 
al. 2011). In Lithuania and Poland, anti-chlamydial antibodies were also detected in 
commercial pigs, albeit to a lesser extent, with reported seroprevalence rates of 8% and 6% 
respectively (Rypula et al. 2014b). These numerous reports demonstrate the high abundance 
of chlamydial infections in European commercial pigs. Moreover, Chlamydiaceae 
seroprevalence rates in pigs were examined in different provinces of China, with prevalence 
rates of 63% in the Hunan province, 59% in Jiangxi and 31% in the Guangdong province (Xu 
et al. 2010; Jiang et al. 2013; Zhang et al. 2014). Although variation in reported 
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seroprevalence rates exists, Chlamydiaceae infections are believed to be widespread in 
commercial pigs worldwide (Schautteet and Vanrompay 2011). 
5.2.2 Molecular diagnosis 
The development of NAATs enabled species specific examination of chlamydial infections. 
Implementation of species specific tests identified C. suis as the main species involved in 
chlamydial infections in swine. A high prevalence of C. suis was demonstrated in the eyes of 
Swiss and German pigs without ocular symptoms (23-88%), and pigs suffering from 
conjunctivitis (79-90%) (Becker et al. 2007). Similarly, C. suis was detected in Swedish 
finisher pigs with or without conjunctivitis (Englund et al. 2012). Moreover, C. suis was 
involved in the majority of chlamydial intestinal infections in German, Swiss and Belgian 
pigs (Zahn et al. 1995; Szeredi et al. 1996), and in growing pigs with and without diarrhea in 
Sweden (Englund et al. 2012). Furthermore, C. suis was demonstrated in the intestine of 
Cypriot and Israeli pigs (Schautteet et al. 2012). Chlamydia suis was also detected in the 
urogenital tract of pigs suffering from reproductive disorder in Belgium, Cyprus and Israel 
(Schautteet et al. 2012). Moreover, C. suis was also demonstrated in the urogenital tract of 
pigs in Poland (Szymanska-Czerwinska et al. 2011). The urogenital C. suis infections might 
be spread through contaminated pig sperm, since C. suis was detected in boar semen intended 
for export, in a German artificial insemination center (Schautteet et al. 2012). In addition, 
mixed infections of C. suis and C. abortus occur regularly, as has been demonstrated in the 
lungs and intestine of German pigs (Hoelzle et al. 2000). Although C. abortus mainly causes 
reproductive failure and abortions in pigs, it has also been demonstrated in lung tissue (Sachse 
et al. 2005). 
The majority of report on porcine chlamydial infections concern examination on commercial 
pigs. However, few reports exist on wild boars. Hotzel et al. (2004) detected C. suis, 
C. abortus and C. psittaci in the lung tissue of wild boars in Germany (Thuringia), while Di 
Francesco et al. (2013) demonstrated the presence of C. suis in conjunctival swabs of wild 
boars in Italy. These findings suggest a possible wildlife reservoir of porcine chlamydial 
infections. 
5.3 Pathogenesis 
Chlamydia suis is frequently detected in commercial pigs worldwide, often without clinical 
manifestation of infection (Hoelzle et al. 2000; Camenisch et al. 2004a; Englund et al. 2012). 
However, these infections have also been associated with a variety of diseases. The majority 
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of the 25 C. suis strains currently described in literature, were isolated from pigs with clinical 
symptoms, except C. suis S45, 130 and 132 (Table I-4). The pathogenicity of C. suis has been 
demonstrated in experimental infections of gnotobiotic pigs. 
Table I-4 Chlamydia suis strains isolated from pigs (Schautteet and Vanrompay 2011) 
 Isolated from  
Strain Location Year Tissue Clinical Symptoms of the pigs 
S45 Austria 1969 Intestines (feces) Asymptomatic infection 
R19 Nebraska 1992 Intestines (feces) Pneumonia, enteritis, conjunctivitis 
R22 Nebraska 1992 Conjunctiva Conjunctivitis 
R24 Nebraska 1992 Respiratory tract (nasal mucosa) Upper respiratory tract disease 
R27 Nebraska 1993 Intestines (colon) Enteritis 
R33 Nebraska 1994 Respiratory tract (nasal mucosa) Pneumonia 
H5 Iowa 1994 Conjunctiva Conjunctivitis 
H7 Iowa 1994 Conjunctiva Conjunctivitis 
130 Nebraska 1996 Intestines (jejunum) Asymptomatic infection 
132 Nebraska 1996 Intestines (ileum) Asymptomatic infection 
DC6 Germany 2004 Conjunctiva Conjunctivitis 
MS1 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS2 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS3 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS4 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS5 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS6 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS7 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS8 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS9 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS10 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS11 Italy 2004-2007 Conjunctiva Conjunctivitis and return to oestrus 
MS12 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS13 Italy 2004-2007 Conjunctiva Conjunctivitis 
MS14 Italy 2004-2007 Conjunctiva Conjunctivitis 
 
26 Chapter I 
5.3.1 Conjunctival infection 
Conjunctival infection of gnotobiotic piglets with C. suis H7, resulted in histological lesions 
of mild to moderate multifocal conjunctivitis, albeit subclinical (Rogers and Andersen 1999). 
However, C. suis has been associated with clinical signs of conjunctivitis in naturally infected 
pigs (Rogers et al. 1993). Moreover, according to Becker et al. (2007), the occurrence of 
conjunctivitis was correlated to the presence of C. suis in extensively kept pigs. In intensive 
pig-farming systems, however, pigs showed to be predisposed to ocular C. suis infections, 
also leading to a high prevalence in clinically healthy pigs (Becker et al. 2007; Schautteet et 
al. 2010). 
5.3.2 Respiratory infection 
Experimental aerosol challenge in pigs with C. suis DC6 resulted in respiratory infections 
leading to pulmonary inflammation, characterized by severe acute bronchiolitis, interstitial 
pneumonia and dystelectasis, and associated with fever, dry cough, serous nasal discharge and 
dyspnoea in all infected animals (Sachse et al. 2004; Reinhold et al. 2008). Chlamydia suis 
DNA was detected in tissue samples from tonsils, and sporadically in spleen and pulmonary 
lymph nodes of infected pigs, but not in liver samples. The high detection rate of C. suis in 
fecal swabs of infected animals might contribute to airborne transport of Chlamydiae. These 
experimental infections indicate the pathogenic potential of C. suis for the porcine respiratory 
system. Moreover, the involvement of C. suis and C. abortus in respiratory disease has been 
demonstrated in naturally infected pigs showing clinical signs of respiratory illness (Hoelzle 
et al. 2000). 
5.3.3 Intestinal infection 
The pathogenicity of chlamydial isolates for the porcine intestine has also been confirmed in 
experimental infection studies. Although the reference strain C. suis S45 was originally 
isolated from feces of an asymptomatic pig, experimental enteric infection provoked 
significant enteric disease and lesions in gnotobiotic piglets (Guscetti et al. 2009). 
Histopathological changes included moderate-to-severe villus atrophy, associated with 
flattened enterocytes and focal villus tip erosions, and moderate mucosal inflammatory cell 
infiltration in the small intestine of inoculated piglets. Chlamydial replication was observed in 
the small and large intestinal villus enterocytes, lamina propria, tunica submucosa and 
mesenteric lymphnodes. No substantial dissemination into extraintestinal sites, such as spleen, 
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kidney and liver, was demonstrated. Similarly, C. suis isolates R27 and R19 caused diarrhea 
and intestinal lesions in experimentally infected piglets (Rogers and Andersen 1996). 
Likewise, moderate-to-severe multifocal villus atrophy was observed in the distal jejunum 
and ileum of the infected piglets. Chlamydial antigens were also occasionally seen in 
macrophages in the lamina propria and in foci of inflammation in the submucosa. 
Extraintestinal dissemination of C. suis was not evaluated in this study. Furthermore, 
experimental enteric infection of gnotobiotic piglets with a C. psittaci strain T49/90, of avian 
origin, elicited enteric infection associated with mild lesions, weak systemic dissemination 
and fecal shedding. Histopathological lesions consisted again of villus atrophy and an 
increased number of inflammatory cells in the villus epithelium and lamina propria. 
Chlamydial replication was observed in the villus enterocytes and lamina propria. Systemic 
dissemination of Chlamydia into mesenteric lymph nodes, spleen and lung occurred to a 
limited extent. Thus, pigs might also be a potential host for avian Chlamydiae (Guscetti et al. 
2000). Natural intestinal chlamydial infections are frequently detected in both diarrheic and 
clinically healthy pigs (Pospischil and Wood 1987; Szeredi et al. 1996; Nietfeld et al. 1997; 
Hoelzle et al. 2000; Camenisch et al. 2004a; Englund et al. 2012). Therefore, intestinal 
chlamydial infections are common but the majority is believed to remain subclinical. 
 
5.3.4 Urogenital infection 
Recently, De Clercq et al. (2014) demonstrated the pathogenic potential of C. suis for the 
female porcine urogenital tract. Intravaginal infection of piglets with C. suis strain S45 
resulted in inflammation of the reproductive system, associated with lesions and congestion of 
the genital tract. Histopathological changes included degeneration of the epithelium, 
superficial exfoliated epithelial cells and infiltration of inflammatory cells in the lamina 
propria. Chlamydial replication occurred throughout the urogenital tract, but extra-urogenital 
dissemination was not observed. In addition, Vazquez-Cisneros et al. (1994) infected sows at 
42 days of pregnancy with a C. psittaci isolate, originating from aborted ewes. This 
inoculation caused infection of the fetal membranes, but did not induce abortion. No lesions 
other than areas of inflammation were observed. Chlamydial species have been linked to 
various reproductive symptoms in pig farming. Indeed, Eggeman et al. (2000b) demonstrated 
a significant correlation between the presence of chlamydial DNA and the incidence of 
abortion and litters with stillborn and low viable piglets. According to Hoelzle et al. (2000), 
sows with reproductive disorder showed a significantly higher Chlamydia PCR positive rate 
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compared to healthy controls. Yet, in these cases, C. abortus was mainly involved, while 
C. suis was less frequently detected. Furthermore, C. suis, C. abortus and C. pecorum have 
been regularly demonstrated in aborted fetuses (Schiller et al. 1997b; Thoma et al. 1997). 
Besides, C. suis has been associated with various reproductive disorders, including vaginal 
discharge, return to oestrus, endometritis, delivery of weak piglets, increased perinatal and 
neonatal mortality, abortion and mummification (Woollen et al. 1990; Schiller et al. 1997b; 
Camenisch et al. 2004a; Kauffold et al. 2006b; Schautteet et al. 2010; Schautteet et al. 2013). 
In boars, C. suis infections have been related to inferior semen quality, orchitis, epididymitis 
and urethritis (Sarma et al. 1983; Schautteet and Vanrompay 2011). However, given the 
limited number of data on experimental genital tract infections with C. suis in pigs, the exact 
role of C. suis in reproductive disorders remains largely elusive. Finally, Chlamydiae have 
also been linked to arthritis, pericarditis and polyserositis in piglets (Willigan and Beamer 
1955). 
5.3.5 Transmission routes 
Although the pathogenicity of Chlamydiae in pigs has been demonstrated, the insight into the 
transmission route of porcine chlamydial infections is currently limited. The pig intestine is 
assumed to be a reservoir of chlamydial infections. Indeed, fecal shedding of Chlamydiae 
might contribute to oral-fecal transmission or airborne transport of germs on fecal particles. 
Moreover, chlamydial transmission might also occur through exchange of body fluids, like 
excretion from the eyes and nose (Becker et al. 2007). 
 
5.4 Clinical importance of porcine Chlamydiaceae infections 
The pathogenicity of chlamydial species in pigs has been demonstrated in various 
experimental infections, as described above, and natural chlamydial infections in pigs have 
been associated with numerous clinical manifestations and economic losses (Willigan and 
Beamer 1955; Sarma et al. 1983; Woollen et al. 1990; Zahn et al. 1995; Andersen 1998; 
Eggemann et al. 2000b; Schautteet et al. 2013) However, Chlamydiae are frequently detected 
in clinically healthy animals, and the vast majority of chlamydial infections, especially 
intestinal infections, is believed to be subclinical (Pospischil and Wood 1987; Szeredi et al. 
1996; Nietfeld et al. 1997; Hoelzle et al. 2000; Camenisch et al. 2004a; Englund et al. 2012), 
Therefore, Chlamydiaceae are assumed to be endemic in commercial pigs. The ambiguous 
association between infection and clinical disease have raised questions whether 
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Chlamydiaceae are actual pathogens or commensals (Reinhold et al. 2011b). The occurrence 
of clinical disease upon infection was suggested to depend on the virulence and infectious 
dose of the chlamydial agent, and the age and immunological status of the host (Leonhard et 
al. 1988; Szeredi et al. 1996; Englund et al. 2012). Additionally, environmental factors may 
contribute to the emergence of chlamydial disease. Overcrowding in pig herds induces stress, 
which can lead to immunosuppression, thereby pre-disposing pigs towards chlamydial 
infection or a more severe manifestation of infection (Becker et al. 2007). Moreover, several 
cases of pathogenic interaction involving Chlamydiae have been reported. Schautteet et al. 
(2010) described a concurrent outbreak of chlamydial disease in boars, sows and gilts and 
postweaning multisystemic wasting syndrome (PMWS) in weaned piglets on an Estonian pig 
farm, attributed to co-infection with C. suis, C. abortus and porcine circovirus type 2 (PCV-
2). Carrasco et al. (2000) also reported the co-infection of enterocytes with PCV-2 and 
Chlamydia species, associated with intestinal lesions in a 12-weeks-old pig. Therefore, these 
pathogens might trigger each other’s pathology. Moreover, a pathogenic interaction between 
Chlamydia and porcine epidemic diarrhea virus (PEDV) was suggested, based on 
experimental infections in vitro (Stuedli et al. 2005) and in vivo (Grest et al. 2000). 
Furthermore, Pospischil et al. (2009) suggested a synergistic effect between 
Salmonella typhimurium and C. suis in the infection of enterocytes in the swine intestine. Co-
existence of these organisms might alter their destructive or invasive capacity, possibly 
leading to a more severe clinical manifestation compared to single infections of these 
organisms (Pospischil and Wood 1987). Similarly, the coccidium Eimeria scabra was 
suggested to enable Chlamydiae to invade and develop in enterocytes (Koudela et al. 1990). 
Moreover, Becker et al. (2007) demonstrated the synergistic effect of Amoebae and C. suis 
infection in intensive pig farming, leading to serious ocular manifestations. Thus, although 
Chlamydiae are frequently detected in clinically healthy animals, clinical signs of infection 
may appear through synergistic interaction with other pathogenic bacteria, resulting in clinical 
disease. Moreover, enteric Chlamydiae infections, often subclinical, may induce intestinal 
lesions that enhance susceptibility for other enteropathogenic agents (Guscetti et al. 2009). 
Therefore, subclinical infections may be more harmful than generally assumed. 
Interestingly, co-infection with other bacteria can induce persistent chlamydial infections, as 
shown for C. abortus, C. pecorum and PEDV, at least in vitro (Borel et al. 2010). A similar 
induction of chlamydial persistence in vitro was demonstrated for co-infection of 
C. trachomatis with herpes simplex virus type 2 (HSV-2) (Deka et al. 2006). During 
persistence, persistent or ‘aberrant’ RBs are formed, in which DNA replication and protein 
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synthesis proceeds, but cell division no longer occurs, as described above. As a result, a small 
number of very large RBs are present in the inclusions, leading to a chronic infection. These 
persistent bodies are non-culturable, and insensitive to antibiotic treatment. Other factors 
known to induce persistence include antibiotics, nutrient deprivation or immune factors, such 
as interferon gamma (IFN-ɤ) (Mpiga and Ravaoarinoro 2006). Pospischil et al. (2009) 
reported the occurrence of aberrant bodies in vivo, in intestinal tissue derived from pigs 
naturally and experimentally infected with C. suis. The high prevalence of subclinical 
Chlamydiae infections in pigs, especially in the intestines, and the occurrence of persistent 
infections, obscure their potential pathogenic effects (Reinhold et al. 2011b). Moreover, 
although Chlamydiaceae have been associated with various chronic diseases in pigs, they are 
often found together with other pathogens, which make it difficult to attribute the observed 
pathology to chlamydial infections alone. Furthermore, although the pathogenicity has been 
demonstrated in pigs, the reported virulence of C. suis in pigs appears to be highly variable 
(Bush and Everett 2001), which may be the consequence of the high degree of genetic 
diversity in C. suis compared to other chlamydial species (Everett et al. 1999; Bush and 
Everett 2001). Currently, the general view is that Chlamydiae may act in concert with other 
potentially pathogenic agents in multifactorial infectious diseases, such as diarrhea in pigs, 
abortions in sows and genital disorders in boars (Sachse et al. 2009). 
 
5.5 Diagnosis of Chlamydiaceae in pigs 
The diagnosis of chlamydial infections is generally based on (1) the direct detection of the 
bacterial agent or bacterial components, or (2) screening for Chlamydiaceae-specific 
antibodies produced by the host. The preferred test is dependent upon the type of sample, the 
viability of the organism in the specimen, potential presumptive diagnosis based on clinical 
symptoms and pathology, and the clinical history. 
Concerning chlamydial diagnosis, isolation of the pathogen is historically considered as the 
‘gold standard’. Since Chlamydiaceae are obligate intracellular organisms, a host system is 
required to propagate these bacteria. At first, Chlamydiae were cultivated in mice and 
especially developing chicken eggs (Burnet and Rountree 1935; Stamp et al. 1950; Tang et al. 
1957). Therefore, a 10% sample suspension is inoculated into the yolk sac of 6-to-8-day-old 
embryos, which then die between 4 and 14 days p.i. To verify replication of Chlamydiae, 
smear of the yolk-sac membrane can be prepared and stained using various procedures, 
including modified Ziehl-Neelsen (MZN) or Giemsa staining, to demonstrate EBs (Stamp et 
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al. 1950). However, egg culture is an expensive and time consuming procedure, lacks 
reproducibility, and its sensitivity can vary upon chlamydial species and subtype (Sachse et 
al. 2009). Moreover, the regulations concerning experimentation on live embryos have 
become stricter, and appropriate facilities and expertise are required. Although still used for 
massive production of antigens, or propagation of fastidious strains, egg culture is largely 
replaced by cell culture. Various cell lines have been used to propagate Chlamydiae, yet the 
most suitable cell line for chlamydial isolation is species dependent. In case of C. trachomatis 
several cell types can be used, but McCoy, Buffalo Green Monkey Kidney (BGM), and Hela 
229 cell lines appear to be most susceptible (Wills et al. 1984; Barnes 1989; Thewessen et al. 
1989; Johnston and Siegel 1992). Similarly, C. psittaci grows easily in many cell types, but 
BGM, African green monkey kidney (Vero), McCoy, HeLa and L cells are commonly used 
for direct inoculation (Vanrompay et al. 1992). For some C. suis, C. abortus and C. pecorum 
strains, especially from porcine origin, isolation can be challenging. Little information is 
available on the culture of these species. Schiller et al. (2004) studied the growth 
characteristics of porcine chlamydial strains, in different cell culture systems. According to 
this study, human colonic adenocarcinoma cells (Caco) are the most appropriate for isolation 
of problematic C. suis and C. pecorum strains. Other cell lines frequently used to propagate 
laboratory strains of C. suis include HeLa, BGM, Vero and McCoy (Rogers et al. 1996; 
Rogers and Andersen 2000; Lenart et al. 2001; Sachse et al. 2004). Besides the cell line, the 
infection rate of Chlamydiae in cell monolayers is also influenced by the inoculation 
procedure. Centrifugation (1000 to 3000 x g, 1 h, 30 to 37°C) following inoculation is 
generally used to enhance the attachment of Chlamydiaceae to the cells, increasing the 
infection rate up to a 1000-fold (Moulder 1991; Schiller et al. 2004). Moreover, chemicals 
blocking host cell replication and metabolism, such as cycloheximide (1-5 µg/ml), may be 
added to the growth medium during infection to limit the host cell utilization of energy. 
However, the extent of the effect of cycloheximide treatment on chlamydial replication is 
species dependent (Schiller et al. 2004). Overgrowth of fungi or non-chlamydial bacteria is 
impeded through addition of antifungal compounds and antibiotics, including gentamycine 
(10-50 µg/ml) and vancomycin (100 µg/ml), which do not affect chlamydial growth (Sachse 
et al. 2009). After inoculation, the cell cultures are incubated at 37°C for 2-6 days, depending 
on the species, but an additional passage is frequently applied. Then, inoculated coverslip-
monolayers can be fixed and stained, using Giemsa or immunofluorescence staining, for 
detection of chlamydial inclusions. Careful sampling should avoid contamination with 
bacteria that can interfere with the isolation of Chlamydiae. Although the isolation procedure 
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has a substantial impact on the infection rate of the cells, successful isolation of chlamydial 
organisms from biological samples is largely dependent on proper transport and storage of the 
biological samples, to preserve the viability of the organisms (Sachse et al. 2009). Transport 
of samples at 4°C in a suitable transport medium, such as sucrose-phosphate-glutamate (SPG) 
supplemented with foetal bovine serum, is recommended (Spencer and Johnson 1983). 
Although isolation in cell culture has a limited sensitivity compared to nucleic acid 
amplification tests (NAATs) (Sandoz and Rockey 2010), among other limitations, isolation 
remains crucial to assess the viability of field strains and to characterize new individual 
isolates (Sachse et al. 2009). However, chlamydial isolation can be challenging in case of 
persistent infections, when Chlamydiae enter a viable but nonculturable state, as described 
above. This persistent state is induced upon exposure to stress factors, including antibiotics or 
deprivation of amino acids (Chopra et al. 1998; Hogan et al. 2004). Persistent RBs are 
formed, in which DNA replication proceeds but cell division halts, resulting in a prolonged 
infection refractory to antibiotic treatment (Sandoz and Rockey 2010). Persistence can thus 
easily be confused with antibiotic resistant infections, or generate false negative results. 
Immunohistochemical staining on histological sections is regularly used for diagnostic or 
epidemiologic examination, and pathogenesis studies (Juvonen et al. 1997; Tsakos et al. 
2001; Hotzel et al. 2004; Navarro et al. 2004; Borel et al. 2006a; Borel et al. 2006b). 
Monoclonal antibodies directed against surface antigens, including LPS or MOMP, are 
commonly used for detection. These antibodies are either directly linked to the enzyme 
horseradish peroxidase (HRP), or indirectly detected using a fluorescein-conjugated 
secondary antibody (Szeredi et al. 1996; Buxton et al. 2002). In addition to immunodetection 
in histological sections, various immunoassays were developed for detection of chlamydial 
antigens in clinical specimens. Most of these assays are designed for detection of 
C. trachomatis in human samples. Since these tests target family-specific LPS antigens, other 
chlamydial species could be detected as well. However, family-specific antigens do not allow 
species identification. Generally, immunoassays exist in various configurations, including 
fluorescent antibody tests (DFA), plate-based ELISAs and solid-phase ELISAs (Sachse et al. 
2009). However, depending on the specimen type, immunoassays can vary in terms of 
sensitivity and specificity (Eggemann et al. 2000a; Bagdonas et al. 2005). Hence, molecular 
or serological methods are generally preferred for chlamydial diagnosis in animals. 
More recently, molecular methods were developed for detection of chlamydial nucleic acids 
from tissue or swab samples, which remarkably improved the sensitivity and specificity of 
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chlamydial diagnosis. Numerous PCR tests currently exist, although part of these tests lack 
proper validation. Species identification of Chlamydiaceae in pigs through PCR and 
subsequent sequencing is widely used and mainly targets 16S and 23S rRNA signature 
sequences (Everett et al. 1999; Becker et al. 2007; Englund et al. 2012; Di Francesco et al. 
2013), as well as the omp2 and ompA genes (Schiller et al. 1997a; Hoelzle et al. 2000; 
Kauffold et al. 2006b). However, more sensitive species-specific NAATs have recently been 
developed. Sachse et al. (2005) created a 23S rRNA gene based microarray hybridization 
assay, enabling detection of nine chlamydial species in a single assay. The microarray 
procedure consists of a biotinylation PCR, amplifying a 1 kbp fragment of the rRNA operon, 
followed by hybridization of the PCR product to a plastic tube-integrated microchip, 
containing 11 different probes. Detection is performed using a HRP-streptavidin conjugate, 
which enables signal amplification. Species identification is performed based on the obtained 
pattern of coloured spots. Pantchev et al. (2010) developed real-time PCR assays for detection 
of chlamydial species of veterinary importance, including the four species occurring in pigs. 
For C. psittaci, C. pecorum and C. abortus, the ompA gene was targeted, while for C. suis the 
23S rRNA gene was selected to generate a species specific test. However, this C. suis specific 
real-time PCR was developed for veterinary purposes, and also amplifies C. trachomatis 
DNA. Recently, a 23S rRNA based C. suis specific real-time PCR was developed which can 
differentiate between of C. suis and C. trachomatis, and is therefore suited for diagnosis of 
C. suis in human samples (De Puysseleyr et al. 2014b). Furthermore, real-time PCR assays 
based on the ompA and 16S rRNA genes have already been used (Schautteet et al. 2012) for 
detection of C. abortus (Livingstone et al. 2009), C. psittaci (Geens et al. 2005) and 
C. pecorum (Wan et al. 2011) in pig samples. 
Serological examination of animal sera, to detect anti-chlamydial antibodies, has been 
widely used to estimate the prevalence of chlamydial infection in pigs. Since an antibody 
response may result from a present or prior infection, serology is less suitable in 
discriminating infected and vaccinated animals. Moreover, a lag period of at least one to two 
weeks occurs between infection and the appearance of an antibody response. Furthermore, 
sera of piglets may contain maternal antibodies. Therefore, serology and infection status are 
not consistently correlated, which might complicate the interpretation of serology results. In 
addition, the antibody response can vary highly within a pig herd, being also dependent on the 
age of the animal. Therefore, sampling of multiple animals of different age groups results in a 
more realistic estimation of the infection status of the herd. Moreover, sampling at multiple 
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time points enables the detection of titer changes, which are a more accurate indication of 
infection. Nevertheless, serology has important advantages, since sample collection and 
transport are relatively straight forward, and the timing of sampling is less critical. 
Anti-chlamydial antibodies are commonly captured using inclusions, EBs or chlamydial 
antigens. Subsequent detection of the bound antibodies is obtained through the evaluation of 
the consumption of complement (complement fixation test), or through fluorescently labeled 
secondary antibodies (indirect immunofluorescence and micro immunofluorescence (MIF) 
tests). Furthermore, other tags for the secondary antibodies are available, including the 
horseradish peroxidase ezyme (indirect enzyme-linked immunosorbent (ELISA) tests) 
(Sachse et al. 2009). 
Several serological assays have been developed to assess the chlamydial seroprevalence in 
pigs, such as an LPS-based ELISA assay (Wittenbrink 1991), or an ELISA assay based on the 
recombinant MOMP of C. psittaci (Vanrompay et al. 2004). In addition, also the LPS-based 
complement fixation test is widely used to detect anti-chlamydial antibodies in pig sera 
(Szeredi et al. 1996; Rypula et al. 2014a). However, these assays are unable to identify the 
chlamydial species occurring in swine. Moreover, results obtained based on detection of 
chlamydial LPS or EBs should be interpreted with caution, since cross reactions with 
antibodies against other pathogens may occur (Caldwell and Hitchcock 1984; Nurminen et al. 
1984; Brade et al. 1987; Yuan et al. 1992). A serological assay for the specific and sensitive 
detection of antibodies produced in response to C. suis infection, the major chlamydial species 
occurring in pigs, is currently unavailable. 
 
5.6 Treatment and Prevention 
Chlamydial infections in livestock and humans are primarily treated with tetracycline (Tc) 
and derivatives (chlortetracycline, oxytetracycline, doxycycline), since they have a low cost, 
broad spectrum of activity, a low toxicity and an excellent tissue distribution (Chopra and 
Roberts 2001; Michalova et al. 2004). Tetracyclines interfere with the binding of aminoacyl 
tRNAs on the ribosome, and thus impede bacterial protein synthesis. Besides, also macrolide 
antibiotics, including azithromycin which also interferes with protein synthesis, are frequently 
used to treat chlamydial infections in humans, but are more expensive (Martin et al. 1992; 
Rose 1998). However, cases of treatment failure have already been described (Johnson and 
Spencer 1983; Jones et al. 1990; Andersen 1998; Lefevre and Lepargneur 1998; Misyurina et 
al. 2004; Di Francesco et al. 2008) and frequently heterotypic resistance, in which only a 
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small portion of the population displays the resistant phenotype, is observed. In these cases, it 
is not always clear whether persistence or actual antibiotic resistance is involved. Drug 
resistance frequently arises through point mutations, altering the expression or the 
functionality of the antibiotic target, or through insertion of resistance genes into the bacterial 
genome, as summarized by Sandoz & Rockey et al. (2010). Until recently, it was generally 
believed that the acquisition of antibiotic resistance in Chlamydia spp. through lateral gene 
transfer from other organisms was limited, due to their obligate intracellular life cycle. 
However, since 1998, tetracycline resistant (Tc
R
) C. suis strains have been isolated in the 
U.S., Italy, Cyprus, Germany, Israel, Switzerland and Belgium (Andersen 1998; Di Francesco 
et al. 2008; Borel et al. 2012; Schautteet et al. 2012). Dugan et al. (2004; 2007) demonstrated 
that stable Tc resistance in C. suis is associated with the presence of the tet(C) resistance 
gene. In all examined C. suis strains, the tet(C) gene is integrated in the inv-like gene, of 
which the function is still elusive. Moreover, in vitro studies also demonstrated the transfer of 
the tet(C) gene within and among chlamydial species, including C. suis, C. trachomatis and 
C. muridarum, and into clinical isolates from human patients with C. trachomatis (Suchland 
et al. 2009). Infections with Tc
R
 C. suis strains can be treated with quinolones, such as 
enrofloxacin, or macrolides, such erythromycin. However, these antibiotics are more 
expensive compared to Tc, and Tc
R
 C. suis strains are often resistant to multiple antibiotics 
frequently used to treat chlamydial infection, such as azythromycin (Lenart et al. 2001). 
Although the exact mechanism through which C. suis acquired the Tc resistance gene tet(C) is 
still unresolved, the addition of antibiotics into animal feeds has promoted the selection of 
resistant organisms. Although the use of antibiotics as growth promoters is currently no 
longer allowed in Europe, the supplementation of feeds with antibiotics, especially Tc, was 
widespread in the poultry, porcine and live stock industry, to promote growth and counter 
bacterial infections (Sarmah et al. 2006; Castanon 2007; Moulin et al. 2008; Dewulf et al. 
2012; Dewulf et al. 2013). Considering the high prevalence of Tc resistance in porcine C. suis 
isolates (Schautteet and Vanrompay 2011), it might be also the case in other meat producing 
industries, resulting in treatment difficulties and potentially severe economic losses. 
Moreover, perhaps more importantly, there is a potential risk for public health. Contact 
between Tc
R
 and Tc sensitive (Tc
S
) Chlamydia spp. in different settings, including farms, 
veterinary clinics and slaughterhouses, may lead to transfer of the resistance gene and 
associated phenotype, which could then be propagated and selected for in patients treated with 
Tc. This event would interfere with treatment of chlamydial infections, resulting in more 
severe complications and even a higher mortality rate. In order to combat pathogenic bacteria 
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which are untreatable using conventional antibiotics, alternative therapies should be 
developed. Preferably, virulence factors, traits indispensable for pathogenic characteristics, 
are targeted, rather than merely killing the bacteria. Interestingly, Pollman et al. (2005) 
described a probiotic strain of Enterococcus faecium (NCIMB 10415), which reduces the 
transmission of Chlamydiaceae infections from sows to newborn piglets. This strain is 
licensed by the European Union as an animal feed supplement. 
The most optimal approach to protect pigs against Chlamydiaceae infections would be 
vaccine development. However, currently, no vaccines are commercially available. Yet, a few 
preliminary studies with promising results have been performed. Immunization of breeding 
sows with an inactivated C. abortus strain (OCHL03/99), isolated from vaginal discharge of 
sows, elicited a primary and secondary IgG serum antibody response (Knitz et al. 2003). 
Moreover, co-vaccination of an omp1 DNA vaccine and recombinant MOMP lead to a 
protective immune response against C. abortus infections in mice (Zhang et al. 2009). 
Interestingly, De Clercq et al. (2014) demonstrated that initial vaginal C. suis infection creates 
partial protection against re-infection. These findings are promising for the development of an 
effective vaccine. 
 
5.7 Zoonosis 
Chlamydiae are highly prevalent microorganisms, infecting a wide range of animal species. 
Chlamydia trachomatis and C. pneumoniae are well characterized human chlamydial 
pathogens. Chlamydia trachomatis is the most common cause of bacterial sexually 
transmitted disease in humans (Bebear and de Barbeyrac 2009), but also induces ocular 
infections, leading to trachoma and possibly infectious blindness, in millions of people in 
developing countries (Mabey 2008). Chlamydia pneumoniae frequently causes respiratory 
infections in humans and is possibly associated with atherosclerosis (Grayston 1999). Besides, 
animals can be a possible zoonotic source of other chlamydial infections in humans. Two of 
the species occurring in pigs, C. psittaci and C. abortus, are prominent examples of zoonotic 
infections. The zoonotic transmission of C. psittaci from birds to humans through aerogenic 
transmission is well described. The clinical outcome of these infections can vary from 
inapparent to severe pneumonia, with possible fatal outcome without treatment. As mentioned 
earlier, potentially fatal systemic infections, miscarriages and stillbirths in pregnant women 
after exposure to infected sheep or goats have been attributed to zoonotic C. abortus 
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infections (Buxton 1986; Kampinga et al. 2000; Pospischil et al. 2002; Walder et al. 2003; 
Meijer et al. 2004; Walder et al. 2005). 
However, data on cases of zoonotic transmission of porcine chlamydioses and possible modes 
of transmission to humans are scarce. Interestingly, C. suis, the chlamydial species most 
prominently present in pigs, is phylogentically highly related to C. trachomatis (Everett et al. 
1999). Chlamydia suis is frequently detected in the eyes of pigs with conjunctivitis, 
resembling the ocular infection caused by C. trachomatis in humans. Moreover, Dean et al. 
(2013) identified C. suis in eye samples of trachoma patients in Nepal. Furthermore, the 
evaluation of the zoonotic transmission of C. suis in a Belgian pig slaughterhouse, identified 
two human isolates in clinically healthy employees (De Puysseleyr et al. 2014a). Therefore, 
C. suis might have zoonotic potential. 
 
6 BLOCKING CHLAMYDIAL VIRULENCE 
Virulence blockers can be defined as compounds that specifically target virulence 
determinants of pathogenic bacteria, thereby preventing the bacteria to colonize the host and 
allowing the host immune system to clear the infection. As most of these blockers do not 
directly kill the bacteria -they disarm rather than destroy- it is presumed that the evolutionary 
pressure for the development of resistant strains is smaller than with classic antibiotics. 
Popular targets include biofilm formation, bacterial toxins, specialized secretion systems, 
organism-specific virulence gene expression or cell-to-cell signalling, as Rasko and Sperandio 
(2010) elegantly reviewed. For the purpose of this review, we will focus on possible 
mechanisms and compounds that may efficiently block different stages in the chlamydial life 
cycle. 
6.1 Inhibition of adhesion 
The very first interaction between bacteria and their host cell is the process of adhesion to the 
cell membrane. Therefore, in order to effectively prevent bacterial colonization of the host, 
one could already prevent attachment of the pathogen to the host cell membrane. For most 
bacteria, adhesins such as fimbriae (Type1 and 4 pili) or adhesive autotransporters have been 
described. Assembly of these pili by the chaperone/usher pathway can be effectively blocked 
by treatment with so-called pilicides (Aberg and Almqvist 2007). However, the adhesion 
mechanism in chlamydial species remains rather elusive, and pili do not seem to be involved. 
Research should therefore focus on already characterized chlamydial adhesins such as MOMP 
and the pmp-proteins. Such adhesins could effectively be blocked by specific antibodies, 
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thereby neutralizing chlamydial infectivity and reducing colonization by blocking chlamydial 
attachment to epithelial cells. In this respect, it has been shown that monoclonal antibodies 
against MOMP could neutralize chlamydial infection in vitro (Peeling et al. 1984; Peterson et 
al. 1991) and could provide a modest level of protection against infection when administered 
passively to mice (Cotter et al. 1995). Similarly, antibodies specific to PmpD of 
C. trachomatis and C. pneumoniae and Pmp2 and 10 of C. pneumoniae were shown to be 
neutralizing, at least in vitro (Wehrl et al. 2004; Finco et al. 2005; Crane et al. 2006). As 
described above, heparin sulphate-like glycosaminoglycans are also involved in the 
chlamydial attachment process. Monoclonal antibodies specifically directed against heparan 
sulphate specifically bind glycosaminoglycans localized to the surface of C. trachomatis and 
C. pneumoniae and effectively neutralize their infectivity (Rasmussen-Lathrop et al. 2000). 
However, evidence exists that chlamydial bacteria most likely use different mechanisms of 
attachment to the host cell (see above), rendering the development of a general anti-adhesion 
therapy that would completely block chlamydial attachment unlikely. 
The immune system of the host provides protection against potential pathogens. The innate 
immune response serves as first line defense against infection, and is constitutively present 
and rapidly mobilized upon infection. Therefore, innate immunity is essential to prevent and 
control the invasion of pathogens (Wira et al. 2005). The primary defense mechanism at 
mucosal surfaces is the mucosal barrier, containing bacteriocidal and bacteriostatic molecules, 
such as lysozyme and defensins (Quayle 2002; Ganz 2003). Furthermore, commensal 
bacterial species have a protective function. However, when Chlamydia passes through the 
mucosal barrier, the innate immune effectors provide the next line of defense against invading 
bacteria. The innate immune system can recognize microbial structures, which are foreign to 
the host, referred to as pathogen-associated molecular patterns (PAMPs) (Medzhitov and 
Janeway 2000). The PAMPs are recognized by the pattern recognition receptors (PRRs), 
expressed on innate immune cells, including macrophages and dendritic cells. A major group 
of PRRs are the Toll-like receptors (TLRs). The TLR2 and TLR4 receptors have been shown 
to be involved in anti-chlamydial host defense. The chlamydial components recognized by 
TLR4 comprise LPS and Hsp60. However, intact chlamydial organisms can stimulate innate 
immune cells independently of TLR4. The TLR2 receptor colocalizes with the intracellular 
chlamydial inclusion, and is likely involved in signaling from this intracellular location. 
Several components have been suggested as ligands for TLR2, including bacterial 
lipoproteins, lipopeptides, and bacterial porins (Joyee and Yang 2008). Also TLR9 has been 
suggested to modulate immune responses in chlamydial infection. Moreover, other PRRs, 
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such as CD14 or NOD1 (nucleotide-binding oligomerization domain-containing protein 1) are 
probably involved in the recognition of PAMPs (Welter-Stahl et al. 2006; Bas et al. 2008; 
Buchholz and Stephens 2008). The binding of PAMPs on TLRs results in the activation of 
signaling cascades, leading to expression of effector molecules, such as cytokines and 
chemokines, which play a crucial role in the activation of the adaptive immune responses. 
Therefore, TLRs function as a link between the innate and adaptive immune response. The 
molecular mechanisms mediated by TLRs might be exploited to develop therapeutics or 
vaccine adjuvants (Joyee and Yang 2008). Indeed, several studies have demonstrated that 
stimulating TLR9 activity can induce beneficial responses for host protection from chlamydial 
infection (Bandholtz et al. 2002; Pal et al. 2002). Although strictly not considered as 
virulence blocking strategy, TLR activation may be an important mechanism by which 
vaccines lead to protective immunity. Further understanding of TLR signaling events and the 
underlying mechanisms to protective immunity would aid in targeted manipulation of immune 
responses to control chlamydial diseases. 
 
6.2 Inhibition of internalization 
As described above, Chlamydiae induce actin recruitment to the site of infection, followed by 
a localized and temporary nucleation, to facilitate uptake into host cell membrane-bound 
vesicles. The most straightforward way to block internalization would therefore be to interfere 
with this polymerization by treatment with molecules such as cytochalasin, latrunculin, 
phalloidin, taxol or colchicines (Peterson and Mitchison 2002). However, as actin is also 
implicated in other cellular functions such as cell shape or cell migration, the side-effects of a 
similar treatment would be considerable. One would therefore have to focus on the process of 
endocytosis itself to prevent Chlamydiae from invading the host cells. Research could be 
directed towards toxins used by pathogenic bacteria such as Yersinia spp. to prevent 
phagocytosis. Especially proteins such as Yersinia YopH and YopE and 
Pseudomonas (P.) aeruginosa ExoS and ExoT, interacting with small GTPases, which are 
also implicated in chlamydial internalization, could be of interest. These proteins, which are 
T3S substrates, convert Rho family members in an accelerated manner to their GDP-bound, 
inactive states and thus inhibit endocytotic processes (Ernst 2000). 
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6.3 Blocking bacterial proliferation 
Although bacterial proliferation is no virulence determinant sensu strictu, processes currently 
not targeted by classical antibiotics could open possibilities for the generation of novel 
antibacterials. Likewise, interest increases in the FtsZ protein as therapeutic target in the 
antimicrobial research field. This protein is essential for bacterial cell division and thus 
targeting FtsZ would lead to disruption of cell division and therefore bacterial infection 
(Awasthi et al. 2011). However, as mentioned earlier, Chlamydiaceae do not possess an ftsZ-
ortholog. Nevertheless, some interesting alternative mechanism to inhibit bacterial 
proliferation exist, such as the limitation of Fe
3+
 availability, which is crucial in the bacterial 
metabolism and biofilm formation (Raulston 1997; Cianciotto 2007). 
The Chlamydiaceae proliferate predominantly in epithelial cells and macrophages 
(Vanrompay et al. 1995). The latter play an important role in the clearance of aged and 
apoptotic cells and are therefore continuously exposed to high intracellular iron loads. Though 
the mode of Fe
3+
 scavenging from the environment by Chlamydia and other intracellular 
bacteria such as Legionella or Mycobacterium, is largely undefined, the cytosolic iron pool is 
most likely the source. Accordingly, depletion of cytosolic iron could limit the growth of 
intracellular bacteria. This concept is demonstrated by the incubation of C. psittaci– or 
L. pneumophila–infected mouse macrophages with iron chelators deferriprone or desferasirox 
which results in a reduced level of bacterial infections (Paradkar et al. 2008). Both 
compounds, deferriprone and desferasirox, have previously been approved for human use. 
They are membrane permeable as they can remove iron from iron loaded macrophages 
(Paradkar et al. 2008). This new generation of chelators has great therapeutic potential for 
treatment of persistent bacterial infections. 
An alternative strategy to limit intracellular Fe
3+-levels is the use of the ‘Trojan horse’ 
transition metal gallium (Ga
3+
), an ion chemically similar to iron. Unlike Fe
3+
, it does not 
undergo redox reactions and thus cannot execute the cellular functions of Fe
3+
 within the 
bacterial cell (Chitambar and Narasimhan 1991). Through competition with Fe
3+
, gallium 
decreases thus bacterial iron uptake. Consequently, the iron need of the bacteria is not 
fulfilled and bacterial growth is inhibited. Furthermore, gallium proved to be effective both in 
vitro and in vivo in treatment of P. aeroginosa infections in rabbit and mouse models (Kaneko 
et al. 2007; Banin et al. 2008) and is already approved by the Food and Drug Administration 
for use in large doses to treat hypercalcemia of malignancy (Warrell and Bockman 1989). All 
together, this hints gallium as a promising treatment strategy in bacterial infections. 
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6.4 Inhibition of nucleotide transport 
As mentioned above, Chlamydiaceae scavenge energy molecules from the host using NTTs. 
These proteins not exclusively constitute bacterial membranes, but are similarly essential to 
plant chloroplasts where they participate in the import process of cytosolic ATP under certain 
conditions (Winkler and Neuhaus 1999; Linka et al. 2003). Interestingly, the bacterial and 
plant transporters do not exhibit structural similarity with mitochondrial and peroxisomal 
adenylate transporters, belonging to the mitochondrial carrier (MC) family. (Klingenberg 
1989; Saier 2000; Ren et al. 2004). Hence, NTTs are absent in mammalian and human cells 
and thus represent an attractive target for the development of highly specific anti-chlamydial 
drugs. However, how the highly charged ATP molecules pass the inclusion membrane to 
reach the bacteria is unknown so far, as pores for passive diffusion are absent in the inclusion 
membrane (Heinzen and Hackstadt 1997). As earlier stated, the genome of C. trachomatis and 
C. pneumoniae contains genes that might encode enzymes involved in ATP generation 
(Stephens et al. 1998; Kalman et al. 1999). However, Chlamydiae also possess ATP/ADP 
anti-porter genes, probably acting to import ATP from the host cell early in the infection 
cycle, when the enzymes for ATP generation are not present yet (Shaw et al. 2000). Since 
NTTs are not present in human cells, and energy parasitism in the initial phase of the infection 
process is crucial for the survival of Chlamydia, blocking this transport process could be a 
specific and efficient strategy in controlling chlamydial infections. To our knowledge, there 
are currently no inhibitors of chlamydial nucleotide transport identified. 
6.5 Inhibition of the Type III secretion system 
As described above, T3S is involved in different stages of the chlamydial life cycle and 
mediates translocation of virulence related effector proteins to the host cell cytoplasm 
(Beeckman and Vanrompay 2010). Consequently, chlamydial disease might be effectively 
treated by either blocking T3S or inhibiting the interaction with the eukaryotic host. In recent 
years, several studies describing small molecules specifically inhibiting T3S have been 
published (Kauppi et al. 2003; Keyser et al. 2008). These inhibitors have been identified 
through mass screening of chemical libraries using whole-cell reporter gene assays or ELISA 
to assess inhibition of T3S and included salicylideneacylhydrazides, salicylanilides, 
sulfonylaminobenzanilides, salicylideneanilides, phenoxyacetamides, thiazolidones and N-
hydroxybenzimidazoles (Keyser et al. 2008; Aiello et al. 2010; Escaich 2010). In the 
Chlamydia research community, research has predominantly focused on the effects of 
acylated hydrazones of salicylaldehydes whereby host cell cytokine expression as well as 
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chlamydial growth and T3S gene expression, but not entry, were shown to be affected at non- 
or low-cytotoxic concentrations (Muschiol et al. 2006; Wolf et al. 2006; Bailey et al. 2007; 
Slepenkin et al. 2007; Muschiol et al. 2009; Prantner and Nagarajan 2009; Chiliveru et al. 
2010). Wang et al. (2011) identified putative target proteins of the salicylideneacylhydrazides, 
which are involved in the regulation of T3SS gene expression. In addition, the 
phenoxyacetamide MBX 1641 is capable of inhibiting T3S translocation in C. trachomatis 
infected Hep-2 cells (Aiello et al. 2010). Although the exact mode of action has not yet been 
uncovered, it is very likely that the conserved (structural) elements of the T3SS or its’ 
assembly are targeted, especially given the broad spectrum of bacteria inhibited. 
Another strategy is to screen for natural products inhibiting bacterial T3S. Such components 
have been described, including glycolipids (Linington et al. 2002; Linington et al. 2006) and 
transferrins (Gomez et al. 2003; Ochoa et al. 2003; Ochoa and Clearly 2004; Yekta et al. 
2010), of which lactoferrin (LF) and ovotransferrin (ovoTF) have proven their potential to 
inhibit chlamydial infections in vitro as well (Beeckman et al. 2007). Moreover, ovoTF was 
shown to efficiently prevent C. psittaci infection in experimentally infected SPF turkeys (Van 
Droogenbroeck et al. 2008) and on a commercial turkey farm (Van Droogenbroeck et al. 
2011). Alternatively, the chlamydial T3S can also be inhibited in a pure mechanical manner. 
Several studies have been published describing in vitro and in vivo blockage of T3S using 
antibodies directed against the translocon adaptor protein LcrV and its analogues in other 
bacteria (Frank et al. 2002; Goure et al. 2005; Philipovskiy et al. 2005; Gebus et al. 2008; 
Eisele and Anderson 2009; Markham et al. 2010; Van Blarcom et al. 2010). Whether the 
LcrV protein is essential in the chlamydial internalization process as well could be studied 
while infecting epithelial cells and/or macrophages in the presence of anti-LcrV antibodies. If 
indeed anti-LcrV antibodies could significantly inhibit C. psittaci internalization and 
subsequent replication in vitro, one could test whether active immunization with LcrV or 
passive immunization with anti-LcrV antibodies could provide protection against C. psittaci 
infections in vivo as well (Mueller et al. 2008). Recently, a chlamydial T3S effector protein 
(Tarp) was identified as a novel immunodominant antigen in human antisera and 
immunization with Tarp can induce protective immunity against chlamydial infection and 
pathology in mice (Wang et al. 2009). Information on other T3S effectors in Chlamydiaceae 
is scarce, put potential targets for antibody-mediated inhibition could include the Chlamydia 
protein associated with Death Domains CADD, the serine-threonine kinase Pkn5 or the 
macrophage infectivity potentiator MIP (Beeckman and Vanrompay 2010). 
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6.6 Regulation of virulence gene expression -Quorum sensing inhibitors 
Blocking QS is increasingly considered as a viable approach for developing therapeutics in 
the treatment of bacterial infections. The ideal QS inhibitor (QSI) is a chemically stable, low-
molecular mass molecule without toxic side-effects on the bacterium or host, and resistant to 
metabolisation and disposal by the host. It should be specific for the particular regulon and 
have a significant and similar reduction in expression on all the QS regulon comprised genes, 
however this is not always the case. The strength of an inhibitor depends on the percentage of 
QS-controlled genes it targets (Arevalo-Ferro et al. 2003; Hentzer et al. 2003; Rasmussen et 
al. 2005b). QSIs fall roughly into three categories according to the level of interruption of the 
signalization: repressors of signal generation, disruptors of the signals or signal molecules and 
inhibitors of the signal perception. Alternatively, inhibitors are categorized into four different 
classes: nonpeptide small molecules, peptides, enzymes and antibodies (Pan and Ren 2009). 
To our knowledge, no chlamydial QSI compounds are currently known. As there is evidence 
that Chlamydiaceae can sense the redox-state of their environment, blockage or destruction of 
receptor proteins could be an interesting strategy for therapeutic purposes in this context. One 
method for receptor blockage is the use of an analogue of the signal molecule. More 
knowledge about the signal perception is needed to explore this possibility. Generally, a 
synthetic library of signal molecule derivatives is used to screen for inhibitors. Yet, random 
compound libraries with natural and synthetic compounds may also be employed (Smith et al. 
2003b; a; Suga and Smith 2003). In both cases, a screening system and further validation is 
necessary to be able to identify potential inhibitors. A valuable source for QSI compounds are 
other bacteria, fungi and plants. These organisms have co-existed for millions of years and 
some of them probably produce QSI compounds, such as Penicillium species for example 
(Rasmussen et al. 2005b). Examples of plants producing QSIs are garlic, carrot, soybean, 
tomato, among many others (Rasmussen et al. 2005a). 
Beside the species specific inhibitors discussed above, also broad spectrum inhibitors are 
already described in literature. Most QS signals only appear in a small number of species. 
However, certain signaling pathways are common in a range of species, while they are not 
found in the eukaryotic hosts. A high throughput screen of a library of 150.000 small organic 
compounds identified the lead structure LED209 (N-phenyl-4-[[(phenylamino) 
thioxomethyl]amino]-benzenesulphonamide). This non-toxic compound has no effect on 
pathogen growth but blocks binding of signaling molecules to QseC, thus preventing the 
autophosphorylation of QseC and consequent activation of virulence genes. LED209 was 
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tested for its inhibitory effect, and showed a virulence decrease in models of infection for 
several pathogens both in vitro and in vivo (Rasko et al. 2008). Furthermore, molecular 
concentrations showed a 10-fold reduction compared to previously characterized virulence 
inhibitory compounds. LED209 can be considered as the proof of concept that blocking inter-
kingdom chemical signaling is a viable strategy to develop novel drugs to control bacterial 
infection. Unlike the LED209 compound mentioned above, most inhibitors show efficacy in 
vitro, but have not been tested in vivo in animal models yet. This partially explains why no 
QSI is at clinical stage of drug development, and thus no information on their efficacy or 
toxicity in humans is available. Therefore, more research in the field of QS and in vivo testing 
is required in order to explore the potential, advantages and limitations of QSIs as therapeutics 
in the control of bacterial infections. 
6.7 Conclusion 
Antibiotic resistance has been reported in Chlamydia. Virulence blockers could fulfill a role 
in future prevention and/or treatment of Chlamydia infections, as they do not directly inhibit 
the growth of pathogens, but rather target virulence associated processes. Therefore, they are 
considered to exert a lower selective pressure to develop resistance compared to classic 
antibiotics. So far, only ovoTF, the avian homologue of mammalian LF, has been tested in an 
animal (turkeys) model and in veterinary clinical trials. Ovotransferrin efficiently prevented 
C. psittaci respiratory disease in commercially raised broiler turkeys demonstrating its 
potential for veterinary use. 
To our knowledge, anti-virulence strategies for human chlamydial infections have not been 
implemented in animal models or human clinical trials. Nevertheless, promising virulence 
blockers such as deferriprone and desferasirox are already approved for human use. 
Further in vivo testing of innovative candidate virulence blockers as well as in vivo testing in 
animal models and clinical trials is required, not only to assess the potential of Chlamydia 
virulence blockers, but also to study possible limitations and safety. 
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Abstract 
Chlamydia suis infections are endemic in domestic pigs in Europe, and can lead to 
conjunctivitis, pneumonia, enteritis and reproductive failure. Moreover, the knowledge of the 
zoonotic potential of Chlamydia suis is limited. Furthermore, the last decades, tetracycline 
resistant Chlamydia suis strains have been isolated, which might interfere with treatment of 
chlamydial infections in pigs and humans. In this study, the presence of Chlamydia suis was 
examined on nine Belgian pig farms, using a Chlamydia suis specific real-time PCR and 
Chlamydia culture in both pigs and farmers. Moreover, farmers were examined using a 
Chlamydia trachomatis PCR. Additionally, the Chlamydia isolates were tested for the 
presence of the tet(C) resistance gene. Chlamydia suis DNA was demonstrated in pigs on all 
farms, and eight of nine farmers were positive in at least one anatomical site. None of the 
farmers tested positive for Chlamydia trachomatis. Chlamydia suis isolates were obtained 
from pigs of eight farms. Nine porcine tetracycline resistant Chlamydia suis strains were 
retrieved, originating from three farms. Moreover, Chlamydia suis isolates were identified in 
three human samples, including one pharyngeal and two rectal samples. These findings 
suggest further research on the zoonotic transfer of Chlamydia suis from pigs to humans. 
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1 INTRODUCTION 
Chlamydiaceae are obligate intracellullar Gram-negative bacteria causing infections in a 
broad range of animals, including humans. Chlamydiaceae infections are assumed to be 
widespread and considered as endemic in domestic pigs in Europe (Eggemann et al. 2000b; 
Camenisch et al. 2004a; Di Francesco et al. 2006), including Belgium (Vanrompay et al. 
2004). Pigs are the only currently identified natural hosts for Chlamydia (C.) suis. 
Additionally, C. abortus, C. psittaci and C. pecorum have been isolated from pigs (Schautteet 
and Vanrompay 2011). Chlamydia psittaci and C. pecorum are of lower significance, 
although C. pecorum DNA was demonstrated in boar sperm samples, fetuses and pig 
intestinal tissue (Thoma et al. 1997; Kauffold et al. 2006b). Meanwhile, C. abortus and 
especially C. suis seem to be the main species involved in chlamydial infections in pigs, and 
mixed infections occur regularly, e.g. in the lung and intestine (Szeredi et al. 1996; Hoelzle et 
al. 2000). Chlamydia abortus causes abortion in pigs (Schautteet and Vanrompay 2011), but 
has also been detected in lung tissue (Sachse et al. 2005). Chlamydia suis was associated with 
conjunctivitis in intensively kept German, Estonian and Swiss pigs (Becker et al. 2007; 
Schautteet et al. 2010). Furthermore, C. suis was involved in reproductive failure, including 
return to oestrus in sows and inferior semen quality in boars, on farrow-to-finish herds in 
Belgium, Cyprus, Estonia, Germany, Israel and Switzerland (Wittenbrink 1991; Eggemann et 
al. 2000b; Hoelzle et al. 2000; Camenisch et al. 2004a; Schautteet et al. 2010). In addition, 
intestinal C. suis infections are believed to be common in Belgian, German and Swiss pigs, 
albeit the majority without clinical signs (Nietfeld et al. 1993; Rogers and Andersen 1996; 
Szeredi et al. 1996). 
Chlamydia suis is phylogenetically highly related to the human pathogen C. trachomatis, 
which causes a sexually transmitted disease in humans, but also keratoconjunctivitis and 
infectious blindness. This close relation suggests that C. suis might cause zoonotic infection. 
Recently, the presence of C. suis was demonstrated in eye infections in Nepalese trachoma 
patients (Dean et al. 2013) and Belgian abattoir employees (De Puysseleyr et al. 2014b). 
Hence, also pig farmers, who are daily in close contact to pigs, might be at risk for C. suis 
infection. Therefore, the presence of C. suis DNA and viable C. suis organisms was examined 
in pigs and farmers on nine Belgian farms. 
Currently, clinical C. suis infections in domestic pigs are complicated by treatment failure. 
Chlamydial infections are routinely treated with relatively inexpensive and effective 
tetracyclines (Tc) (Chopra and Roberts 2001). However, since 1998, Tc resistance has been 
discovered in C. suis strains in the US and Europe, possibly due to the feeding of Tc not only 
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to swine, but also to poultry and cattle, as antibiotic growth promoter (AGP) (Chopra and 
Roberts 2001). The emergence of Tc resistant (Tc
R
) C. suis strains required the use of more 
expensive antibiotics such as enrofloxacin (fluoroquinolone), further increasing the economic 
impact of C. suis infections in pigs. Of interest, recent findings suggest that concurrent 
infections of Tc
R
 C. suis and C. trachomatis in an individual treated with Tc, might lead to the 
emergence of clinical Tc
R
 C. trachomatis strains (Suchland et al. 2009). This would impede 
treatment of human C. trachomatis infections. The emergence of Tc
R
 C. suis strains in pigs 
and its detection in humans might thus present a risk to public health. 
The knowledge on the zoonotic potential of C. suis is limited, as described above. Therefore, 
the prevalence of C. suis in pigs and farmers, was investigated on nine Belgian pig farms. 
Furthermore, the occurrence of tet(C) transfer in vivo remains poorly understood. Thus, all 
identified porcine and human C. suis isolates were examined for the presence of the tet(C) 
gene. Additionally, the farmers were investigated for C. trachomatis infection. 
 
2 MATERIALS AND METHODS 
2.1 Samples 
In the summer of 2011, pigs and farmers (informed consent) in nine voluntarily participating 
Belgian pig farms located in East- (n = 3) and West-Flanders (n = 6) were examined (Table 
II-1). On each farm, 10 finishers (finisher pigs, mean age of five months) and five sows (mean 
age of three years) were sampled, taking a rectal, vaginal, conjunctival and nasal rayon-tipped 
aluminum-shafted swab (Copan, Fiers, Kuurne, Belgium). All farmers (eight males and one 
female) were examined by taking a conjunctival, nasal, pharyngeal and stool swab. Sampling 
in pigs and humans was performed in duplicate, taking one swab for PCR analysis and an 
additional one for culture. Swabs for PCR analysis were stored in DNA/RNA stabilization 
buffer (Roche, Mannheim, Germany), whereas the swabs for culture were stored in 
Chlamydia transport medium (2-SP). Farmers also provided one first void morning urine 
sample. All samples were transported on ice (4°C) and stored at -80°C until tested. 
The farmers were questioned about the general health status, use of medication, and clinical 
signs/history in their pig herd. Furthermore, the farmers filled out a medical questionnaire, 
designed to assess information on their professional (work environment) and nonprofessional 
activities, general health status, smoking habits, use of medication, allergies and clinical 
signs/history. 
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Pigs were sampled with the farmers’ consent for diagnostic purpose. The study was approved 
by the medical ethical committee of Ghent University (approval EC UZG 2011/459). 
Table II-1 Information on investigated Belgian pig farms 
Farm Location Farm Type 
Sperm source for 
insemination 
Antibiotic 
Treatment* 
1 West-Flanders Farrow-to-finish Semen center Tc 
2 West-Flanders Farrow-to-finish Semen center Dc 
3 West-Flanders Farrow-to-feeder Semen center Tc 
4 West-Flanders Farrow-to-finish Semen center Tc 
5 West-Flanders Farrow-to-finish Semen center Tucoprim 
6 East-Flanders Farrow-to-finish Semen center Tc 
7 East-Flanders Farrow-to-finish Semen center Tc 
8 East-Flanders Farrow-to-finish Semen center / 
9 West-Flanders Farrow-to-finish Semen center Dc 
* Within one month before sampling; Tc= tetracycline; Dc= doxycycline 
 
2.2 DNA extraction 
DNA extraction on Chlamydiae present in DNA/RNA stabilization buffer and Chlamydia 
positive cell culture harvest was performed as described by Wilson et al. (1996). Briefly, 
specimens were centrifuged (13 000 x g), resuspended in 198 μl STD buffer (0.01 M Tris-HCl 
[pH 8.3], 0.05 M KCl, 0.0025 M MgCl2.6H20, 0.5% Tween20), and 2 μl proteinase K (20 
mg/ml stock solution) was added. The specimens were incubated at 56°C for one hour and 
subsequently heated at 100°C for 10 min. The DNA samples were further purified by 
extracting them twice with 200 μl phenol:chlorophorm (1:1). Precipitation was performed by 
adding 20 μl sodium acetate (3M) and 400 μl of 100% ethanol (1 h, 80°C). After 
centrifugation (20 min, 4 °C, 16 060 x g), pellets were washed for 5 min with 500 μL of 70% 
ethanol (4 °C, 16 060 x g) and were finally suspended in 30 μl sterile milli-Q water. 
DNA extraction on urine samples was performed with the High Pure PCR Template 
Preparation (HPPTP) Kit (Roche Molecular Biochemicals, Mannheim, Germany), according 
to the manufacturers’ protocol. 
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2.3 PCR analysis on pig samples 
Pig samples were examined for the presence of C. suis using a recently developed, 23S rRNA 
based C. suis-specific real-time PCR (De Puysseleyr et al. 2014b). Samples with a Ct-value 
below 35 were considered positive. Additionally, the samples were tested for the presence of 
C. abortus and C. pecorum, using real-time PCR based on the ompA and 16S rRNA gene 
(Livingstone et al. 2009; Wan et al. 2011), respectively, and for the presence of C. psittaci 
using an ompA based nested PCR (Van Loock et al. 2005). 
2.4 PCR analysis on human samples 
Human samples were tested for C. suis, using the recently developed, 23S rRNA based 
C. suis-specific real-time PCR (De Puysseleyr et al. 2014b) and for C. trachomatis, using the 
CE-IVD certified PRESTO PCR Kit (Goffin Molecular Diagnostics, Houten, The 
Netherlands) according to the manufacturer’s instructions. 
2.5 Cell culture and isolation of Chlamydia 
All animal and human samples were examined for viable Chlamydia by inoculation in Vero 
cells and Chlamydia was identified using the Imagen
TM
 immunofluorescence staining 
(Imagen, Oxoid, United Kingdom), as previously described (Vanrompay et al. 1992). The 
presence of Chlamydiae was scored (Lagae et al. 2014). Briefly, positive cells were 
enumerated in five randomly selected microscopic fields (600 x, Nikon Eclipse TE2000-E, 
Japan) and results were scored from 0 to 5. Score 0 indicated that no Chlamydiae were 
present; score 1 was given if a mean of 1 to 5 non-replicating elementary bodies (EB’s) plus 
maximum one inclusion (EBs and RBs) was observed; scores 2 to 5 were given when 
observing a mean of 2 to 5, 6 to 10, 11 to 15, > 15 inclusion positive cells, respectively. 
2.6 PCR on Chlamydia isolates 
Chlamydia positive cell culture harvest of pig or human inocula was first examined by the 
formerly mentioned C. suis specific PCR. Subsequently, the presence of the Tc resistance 
gene tet(C) was examined in PCR positives by a tet(C) PCR, as described by Dugan et al. 
(2004). 
2.7 Statistical Analysis 
Using a C. suis specific RT-PCR, the number of positive samples (per farm) was determined 
on both animal (finishers/sows) and sample type (eye, nose, vagina and rectum) level 
resulting in a contingency table. The number of positive finishers and sows, testing positive in 
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at least 1 sample type, was compared to each other. Furthermore, we compared the number of 
positives in both groups for each sample type separately. Finally, for both animal categories 
separately, the positive counts were compared between the sample types. Comparisons were 
performed using the chi-squared test. P-values below 0.05 were considered significant 
(p<0.05). The frequency of detection of C. suis isolates in pigs was too low to allow statistical 
comparison. 
 
3 RESULTS 
3.1 PCR on pig samples 
Swabs were all negative for C. psittaci, C. pecorum and C. abortus. On the other hand, C. suis 
DNA was detected on all farms (Table II-2). The number of positive pigs (finishers plus 
sows) per farm ranged from 5 of 15 (33%) to 15 of 15 (100%), respectively. The Ct-values 
varied between 23.42 and 34.82. Each of the four sample types was C. suis positive for at 
least one animal per farm. Overall, 219 of 540 (41%) samples were positive in the C. suis 
real-time PCR. 
3.1.1 Animal level 
The number of C. suis positive finishers per farm ranged from 2 of 10 (20%) to 10 of 10 
(100%). The number of positive sows per farm varied from 0 of 5 (0%) to 5 of 5 (100%). 
Chlamydia suis DNA was detected in 69 of 90 (77%) finishers and 24 of 45 (53%) sows. The 
frequency of positive finishers was significantly higher compared to sows (p=0.006). The 
results per sample type, for finisher pigs and sows separately, are represented below. 
3.1.2 Sample type level 
For the finisher pigs, 51 of 90 (57%) nasal, 43 of 90 (48%) rectal, 41 of 90 (46%) conjunctival 
and 39 of 90 (43%) vaginal swabs tested positive. For the sows, 15 of 45 (33%) rectal, 11 of 
45 (24%) vaginal, 10 of 45 (22%) nasal and 9 of 45 (20%) conjunctival swabs were positive. 
For both the finishers and sows, there was no significant difference between the number of 
positives per sample type (p<0.05). However, when comparing finisher pigs and sows per 
sample type, the number of C. suis positive conjunctival (p=0.004), nasal (p<0.001), and 
vaginal (p=0.032) samples was significantly higher in finisher pigs. 
 Table II-2 - Results of Chlamydia suis real-time PCR analysis on pig swab samples of nine Belgian farms The number of positive samples is represented. The mean 
infection rate (%) was determined.  
FP: Finisher pigs.
 Eye  Nose  Vagina  Rectum  
Tot. N° 
of FP 
(n=10) 
Tot. N° 
of Sows 
(n=5) 
Tot. N° of 
Animals 
(n=15) Farm 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
1 5 1 6  5 2 7  3 0 3  5 1 6  9 3 12 
2 0 2 2  1 1 2  1 1 2  0 1 1  2 3 5 
3 4 0 4  3 2 5  2 0 2  2 1 3  5 3 8 
4 6 1 7  6 0 6  7 0 7  7 0 7  9 1 10 
5 5 0 5  10 0 10  5 5 10  5 5 10  10 5 15 
6 4 0 4  6 0 6  3 0 3  4 0 4  7 0 7 
7 8 0 8  8 0 8  8 0 8  8 1 9  10 1 11 
8 8 4 12  10 4 14  7 3 10  5 5 10  10 5 15 
9 1 1 2  2 1 3  3 2 5  7 1 8  7 3 10 
Total 41 9 50  51 10 61  39 11 50  43 15 58  69 24 93 
Mean (%) 45.56 20.00 37.04  56.67 22.00 45.19  43.33 24.44 37.04  47.78 33.33 42.96  76.67 53.33 68.89 
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3.2 Chlamydia culture on pig samples 
Isolation of Chlamydia was performed on all pig samples. Viable Chlamydiae were present on 
all nine pig farms. Overall, isolation scores varying between 1 and 2 were obtained, 
corresponding to 1 to 5 non replicating elementary bodies with maximum one inclusion, and 2 
to 5 inclusion positive cells, respectively. In total, 62 samples were positive in culture, 
showing at least one inclusion positive cell, indicating replicating bacteria. 
3.3 PCR on porcine Chlamydia isolates 
The C. suis real-time PCR was performed on all Chlamydia isolates. In total, 50 C. suis 
isolates were identified across 8 of 9 (89%) farms (Table II-3). The number of positive 
animals ranged from 0 of 15 (0%) to 10 of 15 (67%). Further, the results for finisher pigs and 
sows are reported separately. 
3.3.1 Animal level 
For the finishers, C. suis isolates were identified in seven farms, with the number of positive 
animals ranging from 0 of 10 (0%) to 7 of 10 (70%). For the sows, C. suis isolates were 
identified in five farms, with the number of positive sows ranging from 0 of 5 (0%) to 4 of 5 
(80%). In total, C. suis isolates were detected in 30 of 90 (33%) finishers and 12 of 45 (27%) 
sows. The prevalence of C. suis isolates in pigs was too low to allow statistical testing. The 
results per sample type for finisher pigs and sows are represented below. 
3.3.2 Sample type level 
For the finishers, 13 of 90 (14%) rectal, 11 of 90 (12%) conjunctival, 8 of 90 (9%) vaginal 
and 5 of 90 (6%) nasal C. suis isolates were identified, whereas for the sows, 5 of 45 (11%) 
rectal, 4 of 45 (9%) conjunctival, and 4 of 45 (9%) vaginal, but no nasal C. suis isolates were 
identified. 
The Tc resistance PCR was performed on all isolates. The presence of the tet(C) gene was 
demonstrated in nine different finishers across three farms, and all nine animals were positive 
for only one sample type. One vaginal, two nasal, three conjunctival and three rectal samples 
tested positive. 
 
 Table II-3 –Results of Chlamydia suis real-time PCR analysis on porcine chlamydial isolates. Pigs of nine Belgian farms were examined for the presence of viable 
bacteria using Chlamydia culture. All isolates were further identified with the Chlamydia suis specific real-time PCR. The number of positive isolates is represented. The 
mean infection rate (%) was determined.  
 Eye  Nose  Vagina  Rectum  
Tot. N° 
of FP 
(n=10) 
Tot. N° 
of Sows 
(n=5) 
Tot. N° 
of 
Animals 
(n=15) 
Farm 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
FP 
(n=10) 
Sows 
(n=5) 
Animals 
(n=15) 
 
1 5 0 5  2 0 2  2 0 2  2 0 2  7 0 7 
2 2 1 3  2 0 2  1 2 3  3 1 4  7 3 10 
3 0 0 0  0 0 0  1 0 1  0 0 0  1 0 1 
4 0 1 1  0 0 0  1 1 2  2 1 3  3 3 6 
5 2 1 3  1 0 1  2 0 2  2 3 5  6 4 10 
6 2 0 2  0 0 0  0 1 1  1 0 1  2 1 3 
7 0 1 1  0 0 0  0 0 0  0 0 0  0 1 1 
8 0 0 0  0 0 0  0 0 0  0 0 0  0 0 0 
9 0 0 0  0 0 0  1 0 1  3 0 3  4 0 4 
Total 11 4 15  5 0 5  8 4 12  13 5 18  30 12 42 
Mean (%) 12.22 8.89 11.11  5.56 0.00 3.70  8.89 8.89 8.89  14.44 11.11 13.33  33.33 26.67 31.11 
FP: finisher pigs.
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3.4 PCR on human samples 
The set of human (n=9) samples for C. suis detection consisted of nine conjunctival, eight 
nasal, nine pharyngeal, and seven stool swabs (sample total n=33). Moreover, four farmers 
delivered a urine sample, for C. trachomatis detection. Eight of 9 farmers (89%) tested 
positive in the C. suis real-time PCR for at least one sample type (Table II-4). Moreover, 5 of 
8 (62.5%) farmers tested positive for all sample types. Seven of 9 (78%) conjunctival, 7 of 8 
(88%) nasal, 7 of 9 (78%) pharyngeal and 5 of 7 (71%) stool samples were positive for 
C. suis. None of the urine samples tested positive for C. trachomatis. 
 
Table II-4 - Results of Chlamydia suis real-time PCR analysis on human swab samples The number of 
positive samples is shown. 
Farm Eye Nose Throat Feces Total 
1 0 0 0 0 0 
2 1 NA 1 NA 2 
3 1 1 1 1 4 
4 1 1 1 1 4 
5 1 1 1 1 4 
6 0 1 1 NA 2 
7 1 1 1 1 4 
8 1 1 1 1 4 
9 1 1 0 0 2 
Total 7 7 7 5 26 
NA: not available 
3.5 Chlamydia culture on human samples 
Twenty of 33 (60%) of the human samples were positive for Chlamydia culture. The isolation 
scores varied between 1 and 2. Four samples showed at least one inclusion positive cell, 
indicating replicating bacteria. 
3.6 PCR on human Chlamydia isolates 
Three of the human Chlamydia isolates were identified as C. suis, including one pharyngeal 
sample and two rectal samples, originating from three different farmers. The tet(C) gene was 
not detected in any of the human isolates. 
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3.7 Medical questionnaire 
Based on the questionnaire filled in by the farmers, all pigs appeared healthy. However, 8 of 9 
(89%) farmers communicated the antibiotic treatment of their pig herd within one month 
before sampling. 
Five of nine farmers had no health complaints, while four of nine farmers mentioned at least 
one of the following symptoms: disease of muscles and joints, headache, runny nose, cough or 
heart disease. The manifestation of these symptoms did not clearly correlate with the presence 
of C. suis organisms. 
 
4 DISCUSSION 
The present study investigated the prevalence of C. suis DNA and viable C. suis bacteria in 
samples from pigs and farmers on nine Belgian pig farms. An overall prevalence of 69% 
positive animals in C. suis real-time PCR was demonstrated, and 50 porcine C. suis isolates 
were identified, derived from 31% of the animals, across eight farms. Clinical isolates are 
known to have slower growth rates compared to laboratory strains, and often are present in 
low numbers. This makes their isolation and subsequent identification challenging, especially 
for C. suis (Sandoz and Rockey 2010; Schautteet and Vanrompay 2011), which could explain 
the low isolation scores obtained. Nucleic acid amplification tests generally are highly 
sensitive compared to culture, yet they often cannot equal culture methods concerning 
specificity, approaching 100%. Therefore, culture methods are often used for confirmatory 
testing (Johnson et al. 2002; Schachter et al. 2005). Nevertheless, the current study confirms a 
high prevalence of C. suis in all pig herds, while C. abortus, C. pecorum and C. psittaci were 
not involved. However, no clinical signs of infection in the pig herd were reported by any of 
the farmers, suggesting subclinical infection. These findings are consistent with earlier studies 
on the prevalence of Chlamydiaceae spp. in European domestic pigs (Hoelzle et al. 2000; 
Kauffold et al. 2006b; Englund et al. 2012). Moreover, these findings confirm the assumption 
of endemic presence of Chlamydiaceae species in the Belgian commercial pigs (Vanrompay 
et al. 2004; Schautteet and Vanrompay 2011), and the widespread occurrence of subclinical 
intestinal C. suis infections (Nietfeld et al. 1997). 
In this study, the infection rate of finisher pigs showed to be significantly higher compared to 
sows. Furthermore, the presence of C. suis DNA was compared between finishers and sows 
for each sample type separately. The frequency of C. suis DNA in conjunctival, nasal, and 
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vaginal samples was significantly higher for finishers, compared to sows. These observations 
could be attributed to the housing differences of both groups. At sampling, the sows were 
housed separately in boxes with their piglets. The finisher pigs, however, were group housed 
with direct access to feces and body fluids of group members, implying a higher risk for oral-
fecal transmission. According to Becker et al. (2007), the knowledge on the transmission 
routes of these micro-organisms is limited, but it presumably occurs mainly through exchange 
of body fluids, like excretion from the eyes and nose possibly leading to aerosol formation. 
Therefore, housing conditions might contribute to the transmission of chlamydial infections in 
pigs. 
As mentioned earlier, C. suis is highly related to the human pathogen C. trachomatis, and thus 
the zoontic potential of C. suis is likely. Indeed, few reports exist on the detection of C. suis in 
human samples. Dean et al. (2013) already demonstrated the involvement of C. suis in eye 
infections of villagers of Nepal leading to follicular or intense trachomatous inflammation, 
and De Puysseleyr et al. (2014b) demonstrated the presence of viable C. suis bacteria in the 
eyes of two Belgian pig abattoir employees, albeit asymptomatic. In this study, viable C. suis 
bacteria were detected in one pharyngeal and two rectal samples, originating from three 
different farmers. Further clinical and Chlamydia suis specific serological examination of the 
farmers might confirm a C. suis specific serologic response and give more insight into the 
clinical significance of C. suis infections in humans. Furthermore, sequence analysis of the 
identified porcine and human C. suis isolates can clarify if the isolates demonstrated in the 
farmers were the result of a zoonotic transfer. 
As noted earlier, Tc is still the drug of choice in the treatment of chlamydial infections. 
However, since 1998, Tc
R
 strains have been isolated in the United States, Italy, Cyprus, 
Germany, Israel, Switzerland and Belgium (Andersen 1998; Di Francesco et al. 2008; Borel 
et al. 2012; Schautteet et al. 2012). Many of these farms suffered from severe reproductive 
failure, leading to economic loss, such as a drop in conception rate from 90% to 65% at 50 
days following artificial insemination (Schautteet et al. 2012). Moreover, the Tc
R
 C. suis 
strains are often also resistant to more than one antibiotic used in anti-chlamydial treatment, 
such as azithromycine (Lenart et al. 2001). In the present study, the tet(C) gene was detected 
in nine viable C. suis isolates from three distinct farms, which suggests that the presence of 
the tet(C) gene in C. suis is common in the Belgian domestic pig population. As shown by the 
questionnaire, the three corresponding farmers communicated antibiotic treatment of the pig 
herd shortly before sampling. This treatment probably selected for Tc
R
 C. suis strains, since 
Borel et al. (2012) already reported rapid selection for Tc
R
 C. suis strains following antibiotic 
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treatment. Since the resistance was demonstrated in three of the eight farms where pigs were 
treated, selection of Tc resistance upon treatment might be common. 
The emergence of Tc
R
 strains not only complicates the treatment of chlamydial infections in 
domestic pigs, these strains could also imply major public health concerns, as described 
earlier. Tetracycline is used to treat millions of patients with sexually transmitted or ocular 
C. trachomatis infections, in particular in the developing countries, according to the World 
Health Organization (WHO) estimates for 2008 (WHO 2012). Of interest, Suchland et al. 
(2009) already demonstrated the in vitro transfer of the tet(C) resistance gene from naturally 
resistant C. suis R19 strain into a clinical C. trachomatis isolate, leading to a stable Tc
R
 
phenotype. Moreover, Lenart et al. (2001) reported that C. suis R19 and C. trachomatis L2 
are present together within the same inclusion after sequential infection. Thus, C. suis and 
C. trachomatis can grow within close contact in patients infected with both species. This 
contact might enable the transfer of the Tc
R
 to C. trachomatis, leading to Tc
R
 C. trachomatis 
strains, which could be selected in patients treated with Tc. However, in this study, no tet(C) 
gene could be detected among the identified human C. suis isolates. Currently, there are no 
clinical C. trachomatis isolates identified yet, expressing a stable Tc
R
 phenotype. A study on a 
larger, statistically representative human population is recommended. Moreover, research 
should be promoted on preventive or alternative therapeutic measures, such as probiotics or 
vaccines, to tackle C. suis infections in domestic pigs. 
In conclusion, this study demonstrated the presence of viable C. suis bacteria in pharyngeal 
and rectal samples of pig farmers. Moreover, the tet(C) gene was demonstrated in porcine 
C. suis isolates on three pig farms. Possible transfer of this gene into C. trachomatis might 
impose a risk for public health. Therefore, these findings demand further epidemiologic and 
clinical research on (Tc
R
) C. suis infections in pigs and humans. 
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Abstract 
Chlamydia suis is a porcine pathogen widespread in pig farming worldwide. Although the 
majority of Chlamydia suis infections is believed to remain subclinical, Chlamydia suis has 
also been associated with conjunctivitis, pneumonia, reproductive disorder and inferior semen 
quality in pigs. Several Chlamydia suis strains have been isolated from the intestine, 
conjunctiva and respiratory tract of pigs in Europe and the United States. Isolation in culture 
remains crucial for the generation of new isolates and their characterization and pathogenesis 
studies. However, the reports on the growth conditions of Chlamydia suis strains are limited, 
and isolation of Chlamydia suis from field samples is often fastidious. Therefore, the growth 
characteristics of a conjunctival, respiratory and intestinal Chlamydia suis strain were 
examined in six different cell lines, and two chlamydial growth media were compared. The 
results of this study suggest that the preferred cell line for propagation of Chlamydia suis 
differs among strains, and may be divergent from the cell lines currently applied. 
Furthermore, the use of IMDM as chlamydia culture medium may increase the replication of 
Chlamydia suis, yet, this effect is strain and cell type dependent. According to these results, 
an adaptation of the currently used isolation methods to the origin of the concerning 
Chlamydia suis isolate would be appropriate. 
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1 INTRODUCTION 
Chlamydia suis (C. suis) is an obligate intracellular Gram-negative bacterium, belonging to 
the order of the Chlamydiaceae. Since the pig is the only natural host currently identified, 
C. suis is generally known as a porcine pathogen. However, recently, C. suis isolates were 
detected in the eye of Nepalese villagers and Belgian pig slaughterhouse employees (Dean et 
al. 2013; De Puysseleyr et al. 2014b). Nevertheless, the knowledge on the zoonotic potential 
of C. suis is limited. The reference strain, C. suis S45, was isolated from feces of an 
asymptomatic pig in Austria in the late 1960s (Koelbl 1969). Intestinal C. suis infections are 
assumed to be widespread but the majority probably is subclinical (Nietfeld et al. 1997). 
However, the enteric pathogenicity of the reference strain was demonstrated in gnotobiotic 
piglets (Guscetti et al. 2009). Moreover, C. suis infections in pigs have also been associated 
with conjunctivitis, pneumonia and reproductive disorder and inferior semen quality (Nietfeld 
et al. 1993; Rogers et al. 1993; Rogers and Andersen 1996; Rogers et al. 1996; Rogers and 
Andersen 1999; Eggemann et al. 2000b; Rogers and Andersen 2000; Schautteet et al. 2010), 
and several C. suis strains have been isolated from the intestines, conjunctiva and respiratory 
tract of pigs in Europe and the U.S. (Schautteet and Vanrompay 2011). Chlamydiaceae were 
originally cultivated in fertile hen’s eggs. Although this technique is still used for isolating 
fastidious samples, it is largely replaced by cell culture, which is more sensitive compared to 
egg culture. Different cell lines have been used to culture Chlamydiae, but the success of 
isolation is influenced by the cell line, chlamydial species and sample type. Nevertheless, 
successful propagation of Chlamydiae is dependent on the viability of the bacteria, for which 
adequate transport and storage of biological samples is crucial. More recently, numerous 
nucleic acid amplification tests (NAATs) for the detection of chlamydial DNA have been 
developed. Since these tests are not dependent upon the viability of the bacteria and no 
biohazard containment facilities are required to perform analysis, they are far more sensitive 
and convenient, and less labour-intensive and expensive compared to culturing of 
Chlamydiae. Although NAATs are more sensitive, they often cannot equal culture concerning 
specificity, approaching 100%. Furthermore, isolation in culture remains crucial for the 
generation of new isolates and their characterization and pathogenesis studies. Several cell 
lines have been used for chlamydial isolation, with varying success depending on the 
chlamydial species being cultured. The McCoy (mouse fibroblasts), BGM (monkey kidney 
cells), Vero (monkey kidney cells) and HeLa (human cervix cancer cells) cell lines are most 
commonly used (Rogers et al. 1996; Rogers and Andersen 2000; Lenart et al. 2001; Sachse et 
al. 2004). However, some species, such as C. suis, are more difficult to grow, especially from 
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tissue and rectal samples (Wittenbrink et al. 1991; Rogers et al. 1993; Sandoz and Rockey 
2010). Moreover, the recovery rate can differ significantly among C. suis strains, which could 
reflect the high genetic diversity observed within this species (Everett et al. 1999). The 
knowledge on the culture of porcine Chlamydiaceae is limited. Schiller et al. (2004) studied 
the growth characteristics of porcine chlamydial strains, including C. suis S45, in different 
cell culture systems. According to these results, C. suis inclusions were markedly increased in 
number and size in Caco (Human colon adenocarcinoma) cells, compared to Vero cells. 
Moreover, the use of Iscove’s modified Dulbecco’s medium (IMDM) instead of Eagle’s 
minimal essential medium (EMEM) significantly increased the number of C. suis inclusions 
in Vero cells. 
Currently, the isolation of C. suis in culture is laborious and complicated. Moreover, the 
culture recovery rate of C. suis isolates can vary widely. However, isolation of viable bacteria 
is highly valuable for the characterization of individual strains from a diagnostic viewpoint. In 
order to improve culture conditions for C. suis isolates, the growth characteristics of a 
conjunctival, respiratory and intestinal C. suis strain were examined in six different cell lines. 
The BGM, McCoy and Vero cell lines were included, since they are sensitive artificial cells 
routinely used for chlamydial diagnosis and propagation. Moreover, the Caco-2 cells were 
investigated based on the results obtained by Schiller et al. (2004), as described above. There 
are currently no data available on the replication of characterized C. suis strains in cell lines 
from porcine origin. Moreover, the pig intestine is considered as the natural habitat for C. suis 
(Shewen 1980; Englund et al. 2012). Therefore, the swine kidney SK-6 cell line, frequently 
used for porcine virus propagation (Kasza et al. 1972), and the porcine intestinal IPEC-J2 cell 
line (Schierack et al. 2006) were also examined in this study. Moreover, two chlamydial 
growth media were compared. 
 
2 MATERIALS AND METHODS 
2.1 Chlamydial strains 
Three C. suis strains were used in this study. The origin of the strains is listed in table III-1. 
The strains were propagated in McCoy cells, using standard techniques (Vanrompay et al. 
1992). The 50% Tissue Culture Infective Dose (TCID50) of the bacterial stock was determined 
by the method of Spearman & Kaerber (Mayr 1974). The TCID50/ml correlates with the 
number of inclusion forming units (IFU/ml) (Beeckman et al. 2009), and is regularly used for 
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titration of intracellular organisms in cell culture, such as viruses. Strains were diluted in 
sucrose-phosphate-glutamate (SPG) storage medium (218 mM sucrose, 38 mM KH2PO4, 7 
mM K2HPO4, 5 mM L-glutamic acid) and stored at -80°C. 
Table III-1 Origin of the Chlamydia suis strains used to study their growth characteristics in cell culture 
 Isolated from  
Strain Location Year Tissue Clinical Symptoms of the pigs 
H7 Iowa 1994 Conjunctiva Conjunctivitis 
R24 Nebraska 1992 Respiratory tract (nasal mucosa) Upper respiratory tract disease 
S45 Austria 1969 Intestines (feces) Asymptomatic infection 
2.2 Cell cultures 
Chlamydiaceae were cultured on six cell lines: McCoy (Mouse fibroblast cells, CRL-1696 
American Type Culture Collection), Vero (African Green Monkey kidney cells, CRL-1586 
American Type Culture Collection), BGM (Buffalo Green Monkey kidney cells, America 
Culture Type Collection), IPEC-J2 (Intestinal porcine epithelial cells) and SK-6 (Swine 
kidney cells, both obtained from professor Eric Cox, Department of Virology, Parasitology 
and Immunology, Faculty of Veterinary Medicine, Ghent University), and Caco-2 (Human 
colon adenocarcinoma cells, HTB-37 American Culture Type Collection). The McCoy, Vero 
and BGM cells were culture in Eagle’s minimal essential medium (EMEM, Life 
Technologies) supplemented with 10 % calf serum (Life Technologies), 2 mM L-glutamine 
(Life Technologies), 1% MEM vitamins (Life Technologies), and 0.1 mg/ml streptomycin 
and vancomycin. For the Caco-2 cells, this medium was additionally supplemented with 1% 
non-essential amino acids (Life Technologies). The SK-6 cells were cultured in EMEM 
supplemented with 2 mM L-glutamine and 0.1 mg/ml streptomycin and vancomycin. The 
IPEC-J2 cells were cultured in Dulbecco’s modified Eagle medium/Nutrient Mixture F-12 
(DMEM/F-12, Life Technologies) supplemented with 5% calf serum (Life Technologies), 4 
mM L-glutamine, 1% Insuline-Transferrin-Selenium (ITS, Life Technologies), 0.1 mg/ml 
streptomycin and vancomycin, and 5 ng/ml human epidermal growth factor (hEGF, Life 
Technologies). 
2.3 Infection Forming Unit Curve of Chlamydia suis S45 
Depending on the chlamydial species and cell type, EBs and some non-differentiated RBs are 
released from the host cell at 24 to 72 h post infection (p.i.) through lysis. To assess the 
appropriate time point for quantification of replication, shortly before cell lysis, the IFU curve 
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of C. suis S45 was determined. Therefore, McCoy cells were seeded in Chlamydia Trac 
bottles (CTB) at a concentration of 200 000 cells/ml, and infected with 100 µl C. suis S45 
inoculum (10
5
 IFU/ml), following standard procedures (Vanrompay et al. 1992) . The CTBs 
were incubated at 37°C, and Chlamydiae were harvested at 12, 24, 36, 48, 54, 60 and 72 h p.i. 
The IFU/ml of the resulting culture harvest was determined using the method of Spearman & 
Kaerber (Mayr 1974). 
2.4 Chlamydia culture and immunofluorescence staining 
Cells were seeded in 24-well plates (Greiner) and incubated for 24 h at 37°C and 5% CO2. 
Subsequently, culture medium was removed and cells were infected with 10
4
 IFU diluted in 
SPG. All inoculations were performed in duplicate in two independent experiments. The 
monolayers were centrifuged for 1 h at 1300 x g and 37°C. The bacteria were subsequently 
removed and maintenance medium was added, which differed from the growth medium by 
containing 5% fetal calf serum, 2.2 µg/ml cycloheximide and 5.5 mg/ml glucose. 
Additionally, a second maintenance medium was used for comparison, based on Iscove’s 
modified essential medium (IMDM) (further referred to as MEM and IMDM culture medium, 
respectively). For McCoy, Vero, BGM, Caco-2 and SK-6 cells, IMDM was supplemented 
with 5% fetal calf serum, 0.1 mg/ml streptomycin and vancomycin, 2 mg/ml glucose and 
2.2 µg/ml cycloheximide. Additionally, for the IPEC-J2 cells, 1% ITS and 5 ng/ml hEGF was 
added. Cells were incubated at 37°C. At 40 h p.i., maintenance medium was removed and 
monolayers were washed twice with PBS (Sigma) to remove unattached bacteria. The cells 
were fixed with methanol for 10 minutes at -20°C. After washing once more, the cells were 
incubated overnight at 4°C with 40 mg/mL BSA (Sigma) in PBS. Chlamydia suis was 
detected using the Imagen
TM
 Chlamydia immunofluorescence staining (Oxoid, United 
Kingdom), as described by Vanrompay et al. (1992). The kit contains a monoclonal antibody 
directly conjugated to fluorescein isothiocyanate (FITC) and Evans Blue pancellular 
counterstain. The cell nuclei were stained using 1 ng/ml DAPI (4',6-diamidino-2-
phenylindole) (Life Technologies, Belgium) and slides were mounted with Vectashield 
Mounting Medium (Vector Labs, United States). 
 
2.5 High content microscopy and image analysis 
A fully automated inverted Nikon Ti widefield fluorescence microscope (Nikon Instruments, 
Paris, France) was used, equipped with motorized XYZ stage, filter cube turret and shutters. 
Samples were magnified with a 40x Plan Fluor oil objective (numerical aperture of 1.3) and 
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images were acquired with an Andor Ixon EM- CCD camera, yielding a pixel size of 0.276 
µm/pixel. To obtain a representative sample of each condition with minimal edge effects, 
three separate but sufficiently central regions were chosen per slide. Per region a 5-
dimensional hyperstack was recorded, consisting of 16 fields (acquired in a 4x4 mosaic), 5-7 
z-slices (separated by 1µm) and 3 channels (corresponding with the DAPI, Evans Blue and 
FITC channels). 
To analyze the multidimensional files, dedicated macro scripts were written in FIJI image 
analysis freeware (http://fiji.sc, (Schindelin et al. 2012)), which are essentially based on a 
pipeline described before (De Vos et al. 2010). Briefly, the analysis consists of a stepwise 
segmentation of the features of interest, followed by a quantification of the regions of interest. 
Before commencing segmentation, hyperstacks are flattened by means of a maximum 
projection along the Z-axis. Then, presumed Chlamydia containing foci are segmented. To 
this end, the FITC channel images are convolved with a Laplacian filter to enhance the signals 
and automatically thresholded using the isodata algorithm. Only spots larger than 3 pixels are 
taken into account. Subsequently nuclei are segmented with an algorithm that consists of a 
smoothing step (Gaussian blur), an autothreshold (isodata) and a watershed procedure. 
Finally, cells are delineated by direct segmentation of the Evans Blue channel. Cell 
segmentation occurs by seeking a local minimum in the intensity histogram that separates 
background from true signal. Optionally, cells can be separated by conditional region growing 
from the nuclear regions of interest. Once all regions of interest are retrieved, the following 
metrics were derived: mean spot area (MSA, a measure for inclusion size per cell), mean spot 
number (MSN, inclusion number per cell) and mean spot occupancy per cell (CSO, ratio of 
inclusion and cellular surface, an estimate for the overall replication). 
Since less then three biological replicates were generated in this study, no statististical 
analysis was performed on the data. Instead, the observed trends in the data were described. 
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3 RESULTS 
3.1 Infection forming unit curve Chlamydia suis S45 
The IFU curve of C. suis S45 was established to determine the appropriate time point for 
quantification of C. suis replication (Figure III-1). The IFU/ml started to increase from 24 h 
p.i. on, and reached a maximum, when cell lysis occurs, at 48-60 h p.i., and decreased again 
after 72 h p.i. Therefore, replication of the C. suis strains was examined at 40 h p.i. 
 
 
Figure III-1 Infection Forming Unit (IFU) curve of C. suis S45. The error bars correspond to the standard 
error of the mean. 
 
3.2 Comparison of growth characteristics of Chlamydia suis 
The effect of cell line and chlamydia culture medium on the replication of three C. suis strains 
was examined, based on the inclusion size (mean spot size), number of inclusions per cell 
(mean spot number), and the segment of the cell occupied by C. suis inclusions (cellular spot 
occupancy, an estimate of the overall replication). 
3.2.1 Chlamydia suis H7 
For the conjunctival strain C. suis H7 (Figure III-2), the cell line was found to affect the 
inclusion size, inclusion number and inclusion occupancy (Figure III-3). The IMDM 
chlamydia culture medium seemed only to clearly increase the inclusion size in IPEC-J2 cells. 
Yet, the MEM culture medium produced a higher inclusion number in Vero cells, compared 
to the IMDM culture medium. Therefore, the effect of the chlamydia culture medium on the 
evaluated parameters was not consistent, suggesting an interaction between cell line and 
culture medium. 
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For both culture media, the inclusion size was higher in Caco-2 and SK-6 cells compared to 
BGM, McCoy and Vero cells. When cultured with IMDM medium, the inclusion size was 
also higher in IPEC-J2 cells than in BGM, McCoy and Vero cells. However, when 
considering the inclusion number, Caco-2 cells did not seem to produce a higher inclusion 
number compared to the other cell lines. However, the inclusion number did seem to be 
increased in BGM and IPEC-2 cells. Finally, the BGM, Caco-2 and IPEC-J2 cell lines 
generally produced a higher chlamydial replication, characterized as cellular spot occupancy. 
The datapoints of the C. suis H7 replication in IPEC-J2 cells seemed to concentrate at a higher 
spot occupancy value, which suggests a slightly higher replication in these cells. 
 
 
 
 
Figure III-2 – Micrographic images of C. suis 
H7 in cell culture at 40 h p.i. The cells were 
stained with Evans’ blue, DAPI and Imagen
TM
 
Chlamydia stain to visualize the cytoplasm 
(red), the nucleus (blue) and chlamydial 
inclusions (green, also indicated with white 
arrow), respectively. A BGM (Buffalo green 
monkey kidney cells); B Caco-2 (Human colon 
adenocarcinoma cells); C McCoy (Mouse 
fibroblast cells) (Magnification 400x) 
A B 
C 
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Figure III-3 Growth characteristics of Chlamydia suis H7 in cell culture. The growth of C  suis H7 was 
characterized based on the inclusion size (mean spot number), number of inclusions per cell (mean inclusion 
number), and the overall replication (mean cellular spot occupancy). The cell line numbers correspond to BGM 
(1, Buffalo green monkey kidney cells), Caco-2 (2, Human colon adenocarcinoma cells), IPEC-J2 (3,Intestinal 
porcine epithelial cells), McCoy (4, Mouse fibroblast cells), SK-6 (5,Swine kidney cells) and Vero (6, African 
green monkey kidney cells). The datapoints from the MEM and IMDM chlamydia culture medium were 
represented in black and red, respectively. 
 
3.2.2 Chlamydia suis R24 
For the respiratory strain C. suis R24 (Figure III-4), the cell line clearly affected the inclusion 
size, number and overall chlamydial replication (Figure III-5). The effect of the culture 
medium was not consistent among the cell lines, again suggesting an interaction between 
those two factors. 
The inclusion size was higher in McCoy and Vero cell lines compared to the Caco-2, IPEC-J2 
and SK-6 cell lines, for both culture media. When cultured in BGM cells with IMDM 
medium, the inclusion size was also higher compared to Caco-2, IPEC-J2 and SK-6, but not 
when cultured in MEM medium. Moreover, the inclusion size seemed to be decreased in 
Mean Spot Size           Mean Spot Number         Mean Spot Occupancy 
µm
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McCoy cells if C. suis R24 was cultured in an IMDM culture medium, compared to the MEM 
medium. The inclusion number and overall replication was clearly higher in BGM, McCoy 
and Vero cells, compared to Caco-2, IPEC-J2 and SK-6 cells, regardless of the culture 
medium. The Vero cells appeared to produce the highest replication of C. suis R24. 
 
 
 
 
Figure III-4 – Micrographic images of C. suis 
R24 in cell culture at 40 h p.i. The cells were 
stained with Evans’ blue, DAPI and Imagen
TM
 
Chlamydia stain to visualize the cytoplasm 
(red), the nucleus (blue) and chlamydial 
inclusions (green, also indicated with white 
arrow in B and C), respectively. A Vero 
(African green monkey kidney cells); B McCoy 
(Mouse fibroblast cells) C SK-6 (Swine kidney 
cells) (Magnification 400x) 
A B 
C 
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Figure III-5 Growth characteristics of Chlamydia suis R24 in cell culture. The growth of C. suis R24 was 
characterized based on the inclusion size (mean spot number per cell), number of inclusions per cell (mean 
inclusion number per cell), and the overall replication (mean cellular spot occupancy). The cell line numbers 
correspond to BGM (1, Buffalo green monkey kidney cells), Caco-2 (2, Human colon adenocarcinoma cells), 
IPEC-J2 (3,Intestinal porcine epithelial cells), McCoy (4, Mouse fibroblast cells), SK-6 (5,Swine kidney cells) 
and Vero (6, African green monkey kidney cells). The datapoints from the MEM and IMDM chlamydia culture 
medium were represented in black and red, respectively. 
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3.2.3 Chlamydia suis S45 
For the intestinal strain C. suis S45 (Figure III-6), the cell line clearly affected the inclusion 
number and overall chlamydial replication, but no clear effect on the inclusion size was 
observed (Figure III-7). The IMDM culture medium did not increase any of the evaluated 
parameters, yet rather seemed to decrease the inclusion size, number and overall replication in 
the investigated cell lines. 
For the inclusion size, no clear differences were observed among the cell lines. However, 
Caco-2 and IPEC-J2 cells seemed to produce a higher inclusion number and replication 
compared to SK-6 and Vero cells, and to a lesser extent also compared to BGM and McCoy. 
 
 
 
 
Figure III-6 – Micrographic images of C. suis 
S45 in cell culture at 40 h p.i. The cells were 
stained with Evans’ blue, DAPI and Imagen
TM
 
Chlamydia stain to visualize the cytoplasm 
(red), the nucleus (blue) and chlamydial 
inclusions (green, also indicated with white 
arrow), respectively. A Caco-2 (Human colon 
adenocarcinoma cells); B IPEC-J2 (Intestinal 
porcine epithelial cells); C Vero (African green 
monkey kidney cells) (Magnification 400x) 
A B 
C 
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Figure III-7 Growth characteristics of Chlamydia suis S45 in cell culture. The growth of C. suis S45 was 
characterized based on the inclusion size (mean spot number per cell), number of inclusions per cell (mean 
inclusion number per cell), and the overall replication (mean cellular spot occupancy). The cell line numbers 
correspond to BGM (1, Buffalo green monkey kidney cells), Caco-2 (2, Human colon adenocarcinoma cells), 
IPEC-J2 (3,Intestinal porcine epithelial cells), McCoy (4, Mouse fibroblast cells), SK-6 (5,Swine kidney cells) 
and Vero (6, African green monkey kidney cells). The datapoints from the MEM and IMDM chlamydia culture 
medium were represented in black and red, respectively. 
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4 DISCUSSION 
Isolation of the chlamydial pathogens is crucial for characterization of individual strains from 
an epidemiological viewpoint. Successful propagation is dependent on the cell line and the 
chlamydial species being tested (Sachse et al. 2009). However, chlamydial isolation is often 
fastidious, especially for C. suis. Currently, only few studies exist on the growth 
characterization of porcine chlamydial strains in cell culture. Therefore, the replication of 
three C. suis strains of distinct origin was investigated in six different cell lines. Beside BGM, 
McCoy and Vero cells, commonly used for propagation of C. suis strains, two cell lines of 
porcine origin, IPEC-J2 and SK-6, and the human Caco-2 cell line were included. As 
mentioned earlier, Schiller et al. (2004) reported an increase in inclusion number of 
C. suis S45 in Vero when using an IMDM instead of MEM-based culture medium. Therefore, 
these two media were also compared for all strains. The inclusion size, number and overall 
replication per cell was determined. Interestingly, at high multiplicities of infection, multiple 
C. trachomatis inclusions fuse into a single inclusion 10-12 h post infection (Richards et al. 
2013). Since C. suis is phylogenetically highly related to C. trachomatis, fusion of C. suis 
inclusions might also occur. Although the inclusion membrane protein A (IncA) is known to 
be involved in this homotypic fusion process, a complete insight into the mechanism and the 
host factors involved, is lacking (Richards et al. 2013). To clarify the putative change in 
overall replication, the inclusion number and size were also estimated, in addition to the 
overall replication. However, a change in inclusion size or number does not consistently result 
in a higher replication. Indeed, a higher in inclusion size, but lower inclusion number can 
yield an overall replication comparable with other cell lines, as was demonstrated for the 
infection of Caco-2 and SK-6 cells with C. suis H7. This might be the consequence of 
inclusion fusion, as has been demonstrated for C. trachomatis, and might indicate differences 
in host factors, involved in the fusion process, between the cell lines. Moreover, the ‘mean 
spot number’ parameter, determined per cell, might be biased by the cellular size, since larger 
cells may contain more inclusions. Therefore, in this study, the cellular inclusion occupancy, 
reflecting both the effect of the inclusion size and number, was determined to estimate the 
overall replication. The results varied between the C. suis strains investigated. The C. suis 
strain H7 was originally isolated in Iowa in 1994, from the conjunctiva of a pig suffering from 
conjunctivitis. The overall replication of this strain seemed to be higher in BGM, Caco-2 and 
IPEC-J2 cells, and this was the result of a higher inclusion size and/or a higher inclusion 
number. Thus, McCoy, SK-6 and Vero cells appeared to be less susceptible for C. suis H7 
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replication. The respiratory strain C. suis R24 was isolated in 1992 in Nebraska, from the 
nasal mucosa of a pig suffering from upper respiratory tract disease. This strain appeared to 
be more adapted for replication in BGM, McCoy and Vero, which are established cell lines 
for propagation of C. suis. This higher replication resulted from an increase of inclusion size, 
and mainly a higher inclusion number. 
Unlike the other strains, the size of C. suis S45 inclusions did not seem to be affected by the 
cell line or the culture medium. However, the Caco-2 and IPEC-J2 cells produced a higher 
inclusion number and overall replication, compared to SK-6 and Vero cells. This is in 
accordance with the results obtained by Schiller et al. (2004). The Caco-2 and IPEC-J2 cell 
lines are both from intestinal origin, whereas the porcine SK-6 cells are kidney epithelial 
cells. Interestingly, C. suis S45 was isolated in Austria in 1969, from the feces of a clinically 
healthy pig. Indeed, natural intestinal chlamydial infections are frequently detected in the 
intestine of pigs, but the majority of these infections is believed to be subclinical. However, 
experimental enteric infection provoked significant enteric disease and lesions in gnotobiotic 
piglets (Guscetti et al. 2009). Yet, the isolation of C.suis in culture can be very difficult, 
particularly for rectal strains (Sandoz and Rockey 2010), which compromises further 
characterization. Performing isolation on intestinal cell lines, such as Caco-2 and IPEC-J2, 
might thus increase the recovery rate of rectal C. suis isolates. 
 
Effect of cell culture medium 
Cell culture media components have already been shown to influence chlamydial growth. 
Indeed, cycloheximide treatment, inhibiting eukaryotic protein synthesis and thereby reducing 
host cell competition for amino acids (Allan and Pearce 1983), can enhance chlamydial 
infection in cell culture. Moreover, Schiller et al. (2004) reported a significant increase of 
C. suis S45 inclusion number in Vero cells when cultured with IMDM instead of EMEM, as 
mentioned above. In the current study, the inclusion number of C. suis S45 was slightly 
higher in Vero cells cultured with IMDM, yet, the culture medium did not clearly affect the 
replication of C. suis S45. However, the IMDM culture medium increased the inclusion size 
of C. suis H7 in IPEC-J2 cells, although this effect was not reflected in the overall replication. 
Furthermore, the MEM culture medium produced a higher inclusion number and overall 
replication of C. suis H7 in Vero cells, and a higher inclusion size of C. suis R24 in McCoy 
cells compared to the IMDM medium. Thus, the use of the IMDM culture medium does not 
have a general improving effect on the replication of C. suis, but instead appeared to be cell 
line and chlamydial strain dependent. Of interest, the growth characteristics of chlamydial 
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strains in cell culture can vary widely between several studies (Schiller et al. 2004). The 
culture conditions have been shown to strongly influence cell performance, and therefore 
possibly chlamydial replication. Indeed, the passage number of the cells has been shown to 
affect the morphology and proliferation rate of cell lines (Sambuy et al. 2005; Schierack et al. 
2006). Furthermore, the pH and composition of the culture medium might modulate the 
proliferation, motility and differentiation of cultured cells. Also the nature of the substrate 
used might have an impact on the cellular morphology and differentiation. Wyrick et al. 
(1996) observed an influence of the medium depth above infected monolayers on the 
chlamydial inclusion size. Since culture conditions may also strongly affect chlamydial 
replication, results and inconsistencies among different studies should be interpreted with 
caution. 
 
Effect of cell line 
Although Chlamydiaceae are known to infect a variety of cell types, marked differences were 
observed in inclusion number between cell lines. Moreover, the susceptibility of the cells to 
C. suis infection varied among the three investigated strains. This might reflect the efficiency 
of internalization into the host cell. Two possible mechanisms for chlamydial entry have been 
described: zipper-like microfilament dependent phagocytosis (Byrne and Moulder 1978) and 
clathrin-mediated endocytosis (Hodinka et al. 1988). However, the exact nature of both the 
host cell receptors and chlamydial ligands is still largely undefined, but may influence the 
susceptibility of the cell line for chlamydial infection. Moreover, the cell line had an influence 
on the inclusion size of C. suis H7 and R24, but not for S45. Following infection, chlamydial 
inclusion vacuoles efficiently avoid phagolysosomal fusion, but intercept and fuse with 
secretory vesicles of the exocytic pathway to acquire nutrients and membrane components, to 
maintain the integrity of the growing inclusion (van Ooij et al. 2000). Cell line specific 
differences in the underlying molecular mechanisms in exocytic trafficking might influence 
the ability of Chlamydiae to intercept vesicles and thus the susceptibility of a cell line for 
chlamydial replication. Therefore, the divergence in the current results might be attributed to 
biological differences between cell lines and chlamydial strains, changing the effectiveness of 
cell entry or the ability to grow in the host cell cytoplasm, leading to an altered infectivity 
(Knoebel et al. 1997). Indeed, the species C. suis is presumed to be genetically more diverse 
than other chlamydial species, based on DNA sequence analysis of ompA (Everett et al. 1999) 
and the extensive variation in virulence among C. suis strains in pigs (Bush and Everett 2001). 
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In the current study, the growth of C. suis in cell culture was studied using three laboratory 
strains, which were propagated on McCoy cells prior to this study and thus likely adapted to 
replication in this cell line. Yet, McCoy cells did not appear to be the preferred cell line for 
replication of C. suis H7 and S45. This finding strongly indicates further potential for 
optimization of the replication protocol of C. suis. Since laboratory strains are already adapted 
to propagation in culture, they probably not completely reflect the growth characteristics of 
field isolates. Therefore, the study of field isolates in cell culture might also be valuable. 
Indeed, clinical isolates can have an increased cytotoxicity or persistence, can be present in 
very low numbers, and often have slower growth rates compared to laboratory strains (Sandoz 
and Rockey 2010). Still, the preferred cell line for replication appeared to be strain specific in 
this study. 
To conclude, the replication of three laboratory strains of C. suis was compared in six cell 
lines, using two culture media. The preferred cell line for replication and the impact of the 
culture medium varied among strains. Therefore, adaptation of the isolation procedure to the 
origin of the putative isolate might be recommended to improve the recovery rate of C. suis 
isolates. 
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Transmission routes of porcine chlamydial infections 
The pig intestinal tract is the natural habitat for Chlamydiae, and assumed to function as a 
natural reservoir for C. suis, and other members of the Chlamydiaceae (Shewen 1980; 
Englund et al. 2012), from where the pathogen can spread to other organs or animals (Nietfeld 
et al. 1993; Szeredi et al. 1996; Guscetti et al. 2009). Chlamydia suis predominantly causes 
lesion in the small intestine, especially in the distal jejunum and ileum, as observed in 
experimental and natural infections (Nietfeld et al. 1993; Rogers and Andersen 1996). 
Ascending intestinal Chlamydiae due to fecal contamination of the vagina, including 
C. abortus and C. suis, may result in urogenital chlamydiosis in sows (Hoelzle et al. 2000; 
Yeruva et al. 2013). Indeed, the intestinal strain C. suis S45 has been shown to cause 
pathology in the urogenital tract of conventionally raised piglets (De Clercq et al. 2014). 
Moreover, the eye and eye secretions represent an underestimated site of chlamydial 
infections, possibly acting as a source for further spreading of C. suis. Since the eye is an 
immune-privileged organ, it possibly is a preferred site for survival of persistent or resistant 
chlamydial organisms (Becker et al. 2007). Indeed, C. suis was demonstrated in the eyes of 
pigs suffering from conjunctivitis, but is also frequently detected in the eyes of clinically 
healthy pigs (Rogers et al. 1993; Becker et al. 2007). The knowledge on the transmission 
route of Chlamydiae in pigs is limited, but it presumably occurs through exchange of body 
fluids, like the excretion from the eyes and nose. Ocular or nasal discharge in infected animals 
might thus result in respiratory or oral infections, or contribute to aerosol mediated spreading. 
Since the intestine functions as a reservoir, oral-fecal transmission via contaminated feces 
likely contributes to bacterial spreading. Moreover, the detection of C. suis in boar semen 
suggests possible venereal transmission (Eggemann et al. 2000b; Kauffold et al. 2006a; 
Kauffold et al. 2006b). According to Becker et al. (2007), environmental factors might 
predispose pigs to infection or contribute to the transmission of chlamydial infections. Poor 
hygiene is generally considered as a pre-disposing factor for spreading of chlamydial 
infections in swine herds (Eggemann et al. 2000b; Hoelzle et al. 2000). Moreover, the 
detection of C. suis in the conjunctiva in pigs, in ocular symptomatic and asymptomatic 
infections, was shown to be higher in pigs coming from intensive farming systems. In these 
production systems, high concentrations of toxic ammonia, a high relative humidity, and high 
dust concentrations could lead to predisposition to infections, facilitate microbial survival and 
contribute to airborne transmission (Becker et al. 2007; Englund et al. 2012). Recently, the 
zoonotic transmission of C. suis was examined in a Belgian pig abattoir (De Puysseleyr et al. 
2014a). Bioaerosol monitoring demonstrated high amounts of C. suis bacteria in air samples 
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of the intestine processing site. Therefore, transmission of C. suis through contaminated 
aerosols might be possible. 
 
Zoonotic potential of Chlamydia suis 
The wide distribution of subclinical chlamydial infections in pigs raises the question whether 
swine can also act as a reservoir of chlamydial infections for other animal species, including 
humans. Two of the species occurring in pigs, C. psittaci and C. abortus, are well described 
agents of zoonotic infections. Chlamydia psittaci, although less prevalent in pigs, is 
transferred from birds to humans through aerosols, and infections can vary from inapparent to 
severe pneumonia. Moreover, C. abortus infections in pregnant women, following exposure 
to infected sheep and goats, can result in miscarriages and stillbirths (Buxton 1986; Kampinga 
et al. 2000; Pospischil et al. 2002; Walder et al. 2003; Meijer et al. 2004; Walder et al. 2005). 
However, the zoonotic impact of C. suis and C. pecorum is largely unknown. Chlamydia suis 
is phylogenetically highly related to C. trachomatis (Everett et al. 1999), the human pathogen 
which is the leading cause of infectious blindness and sexually transmitted disease worldwide 
(Bebear and de Barbeyrac 2009). Interestingly, C. suis is frequently detected in the eyes of 
pigs suffering from conjunctivitis, resembling ocular C. trachomatis infections (Rogers et al. 
1993; Becker et al. 2007). Recently, Dean et al. (2013) identified C. suis in the eyes of 
trachoma patients in Nepal (Dean et al. 2013), probably originating from domesticated 
animals, including pigs, commonly kept for consumption or agricultural purposes, in these 
communities. Moreover, viable C. suis organisms were isolated from the eyes of two 
employees of a Belgian pig slaughterhouse (De Puysseleyr et al. 2014a), albeit without 
clinical signs of infection. These employees were in close contact to the arriving animals and 
the pig intestine, respectively. These findings support the zoonotic potential of C. suis. To 
assess the zoonotic transmission to pig farmers, we examined the presence of C. suis in nine 
Belgian pig farms in chapter II. Chlamydia suis DNA was demonstrated in eight farmers, and 
three human C. suis isolates were obtained. Evaluation of the serological response to C. suis 
in positive individuals could explain the significance of human C. suis infections. Further 
epidemiological and clinical research on a larger risk population might clarify the impact of 
C. suis infections in humans. 
 
 
 
General discussion and perspectives 81 
Antibiotic resistance in Chlamydiae 
Chlamydial infections in livestock and humans are primarily treated with tetracycline (Tc), or 
one of its derivatives, due to their low cost, high effectiveness, low toxicity and broad 
spectrum of activity (Chopra and Roberts 2001; Michalova et al. 2004). Chlamydiaceae are 
generally highly sensitive to Tc, however, since 1998, stably tetracycline resistant (Tc
R
) 
C. suis strains have been isolated in the U.S., and since then also in Italy, Cyprus, Germany, 
Israel, Switzerland and Belgium (Andersen 1998; Di Francesco et al. 2008; Borel et al. 2012; 
Schautteet et al. 2012). The resistant phenotype is associated with the presence of a resistance 
gene tet(C) in the chlamydial chromosome (Dugan et al. 2004). The exact mechanism through 
which C. suis acquired the tet(C) gene is still unresolved. However, the majority of Tc 
resistance genes are associated with mobile genetic elements, which could partially explain 
their wide distribution among pathogenic, opportunistic and normal flora bacteria isolated 
from the urogenital, respiratory, and gastrointestinal tract of man, animals, and from food and 
the environment (Roberts 1996). The selection and spreading of resistance genes was 
probably promoted through addition of antibiotics to animal feed. Since the 1950s, the 
supplementation of feed with antibiotics, especially Tc, to promote growth and feed 
conversion, and counter bacterial infections, was widespread in the poultry, porcine and live 
stock industry (Novick 1981; Cromwell 2002; Sarmah et al. 2006; Castanon 2007; Moulin et 
al. 2008; Dewulf et al. 2012; Dewulf et al. 2013). Moreover, sulfa drugs, such as sulfadiazine, 
were widely used as feed additives during the 1970s and early 1980s. However, this practice 
resulted in the emergence of several veterinary pathogens exhibiting resistance to these 
antibiotics. Moreover, human health concerns raised associated with the consumption of milk 
and meat from antibiotic-fed animals. Therefore, the in-feed use of subtherapeutical amounts 
of Tc is no longer allowed in Europe since the late 1960s, and the use of antibiotics is now 
generally being reduced. Since January 2006, the addition of AGPs to feed has been 
completely banned by the European Commission (EC Regulation No. 1831/2003). However, 
several studies revealed the persistence of antibiotic resistant populations and resistance 
genes, even in the absence of direct antibiotic selection (Jindal et al. 2006; Walk et al. 2007; 
Stanton et al. 2011), such as on organic pig farms. Indeed, Tc resistance genes are still 
frequently detected in soil and water samples from areas surrounding pig farms. Moreover, 
the pig intestinal flora appears to represent a source of resistance genes, even in apparently 
antibiotic-free animals (Kazimierczak et al. 2009). The extensive in-feed use of Tc likely 
established a favorable environment for acquisition and maintenance of the tet(C) gene by 
C. suis (Dugan et al. 2004). 
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Although supplementation of feed with antibiotics is no longer allowed in Europe, also 
therapeutic treatment of pigs with Tc can select for Tc
R
 C. suis organisms. Borel et al. (2012) 
reported the rapid selection for Tc
R
 C. suis strains after antibiotic treatment of pigs suffering 
from conjunctivitis and diarrhea due to a C. suis infection. This selection for Tc
R
 C. suis 
strains was possibly facilitated by close contact of the pigs. Therefore, the recent 
implementation plan of the European Commission on group housing of sows and gilts 
(Directive 2008/120/EC on the protection of pigs) might contribute to the spread of Tc
R
 
C. suis strains in pig farming in Europe. In chapter II, we demonstrated the presence of the 
tet(C) gene in nine C. suis isolates identified on three Belgian pig farms. Eight farmers 
reported the antibiotic treatment of the pig herd shortly before sampling, confirming the 
results obtained by Borel et al. (2012). Thus, selection of Tc
R
 strains upon treatment appears 
to be common. Since 2012, enormous efforts to sensitize veterinarians and farmers have been 
made, concerning the importance of restricted antibacterial use. As a result, the total 
consumption of antibacterial compounds in the Belgian veterinary medicine decreased with 
12.7% over the past two years, according to the report of 2013 of the Belgian Veterinary 
Surveillance of Antibacterial Consumption (National report 2013 BelVet-Sac). 
 
Tetracycline resistant Chlamydiae in humans 
Although not allowed in all countries, enrofloxacine, a fluoroquinolone antibiotic, is currently 
used to counter Tc
R
 C. suis outbreaks. However, according to Reinhold et al. (2011a), short-
term antimicrobial treatment at dosages recommended for treatment of other bacterial 
infections in pig herds was not effective in eliminating naturally acquired subclinical C. suis 
infections in pigs. Moreover, the fluoroquinolone antibiotics are extensively used in human 
medicine. Wide agricultural use of these drugs might thus increase selection of antibiotic 
resistance, and therefore compromise further effectiveness of antibiotics in both humans and 
animals. Currently, multi-resistance to other antibiotics, including sulfadiazine, azithromycin, 
ofloxacin, and doxycycline, is frequently detected in Tc
R
 C. suis strains (Lenart et al. 2001; 
Suchland et al. 2009). The emergence of multidrug resistance poses a threat especially to 
patients in healthcare settings. However, the emergence of Tc resistance in C. suis might 
imply a major worldwide public health challenge. Suchland et al. (2009) demonstrated the in 
vitro transfer among and within chlamydial species, including from C. suis into clinical 
isolates of C. trachomatis, leading to a stable Tc
R
 phenotype. Moreover, sequential infection 
in vitro can result in the occurrence of C. suis and C. trachomatis within the same inclusion 
(Lenart et al. 2001). Therefore, given the possible zoonotic potential of C. suis, transmission 
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of porcine Tc
R
 C. suis strains to C. trachomatis infected humans treated with Tc, would create 
a favorable environment for transfer of Tc resistance into C. trachomatis. Once a resistant 
C. trachomatis strain is established, cross-serovar transmission through a patient population 
might occur rapidly (Suchland et al. 2009), leading to treatment failure. Ocular C. trachomatis 
strains cause active trachoma in an estimated 84 million people, especially in developing 
countries, and C. trachomatis is the most common bacterial sexually transmitted disease in the 
world, with over 100 million new cases each year (WHO 2012). Therefore, the spread of Tc 
resistance among clinical C. trachomatis strains would affect millions of people worldwide. 
Currently, several documented cases of clinical C. trachomatis isolates exist that exhibited 
resistance to treatment with Tc (Jones et al. 1990; Lefevre and Lepargneur 1998; Somani et 
al. 2000). However, these strains displayed so-called ‘heterotypic resistance’, in which only a 
small proportion of the population survives after exposure to Tc. Moreover, these isolates lost 
their resistant phenotype upon passage in cell culture, or lost viability completely. Hence, no 
clinical C. trachomatis strains that demonstrate stable Tc resistance have been currently 
identified (Jones et al. 1990; Lefevre and Lepargneur 1998; Somani et al. 2000; Suchland et 
al. 2003). Thus, the identification of the tet(C) gene in C. suis is the first, and only, example 
of horizontal acquisition of DNA in any Chlamydia spp. (Greub et al. 2004; Roberts 2005). 
Apart from the tet(C) gene, Chlamydiae in general have not acquired foreign DNA in the 
recent evolutionary past, and their genomes show a high degree of genetic conservation 
(Sandoz and Rockey 2010). Therefore, recombination is considered as a rare event in 
Chlamydiae. However, genomic studies revealed that inter-chlamydial recombination does 
occur, and probably is common. In this respect, Suchland et al. (2009) hypothesized that the 
entry of the tet(C) island into the C. suis genome was challenging, yet transfer among strains, 
and even species, is straightforward and might perhaps occur rapidly. Therefore, although the 
genetic evidence of antibiotic resistance in C. trachomatis is currently lacking, vigilance for 
the possibility in the future is recommended. 
 
Diagnostic considerations 
Many reports on the prevalence of Chlamydiaceae in pigs are based on PCR-detection of 
Chlamydiae, since these tests allow rapid, sensitive and specific identification, directly from 
clinical specimens (Sachse et al. 2009). Yet, the false positive rate of NAATs, predominantly 
due to contamination, can be considerable. Also false negative results are of significant 
concern, possibly resulting from the presence of inhibitory substances, occasional failure of 
DNA extraction procedures, or the emergence of sequence variation in the targets of the assay 
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(Whiley et al. 2008). Moreover, DNA-based detection does not reflect the viability of the 
detected organisms. In some cases, additional isolation of the involved chlamydial bacteria is 
required, such as in regard to the examination of antibiotic resistant infections. However, the 
accurate diagnosis of antibiotic resistance encounters some challenges. Antimicrobial 
susceptibility assays rely on the isolation of the involved chlamydial strain in host cells, and 
subsequent culture in the presence of multiple antibiotic dilutions (Sandoz and Rockey 2010). 
Also the PCR-based detection of the tet(C) gene described by Dugan et al. (2004) 
preferentially includes prior isolation, since this assay in not Chlamydia-specific. Various cell 
lines and techniques are used in different diagnostic laboratories, which complicates the 
accurate evaluation and monitoring of antibiotic resistance. Moreover, multiple factors can 
influence the outcome of an antibiotic susceptibility analysis, including the nature and passage 
number of the cell line and Chlamydiae, the multiplicity of chlamydial infection, and the 
developmental stage when the antibiotic is added to the infected cells (Wang et al. 2005). 
Hence, small differences in the methodological approach further challenge the interpretation 
of in vitro resistance and its clinical relevance. In addition, clinical isolates, can be highly 
fastidious to grow, especially from rectal samples, and generally have much slower growth 
rates compared to laboratory strains. This is particularly the case for C. suis strains, yet, there 
are relatively few reports on the growth conditions of porcine C. suis isolates. Therefore, in 
chapter III, we characterized the growth of three C. suis strains of distinct origin on different 
cell lines. Interestingly, these results revealed that for two of the examined strains, the cell 
line that produced the highest replication level, differed from McCoy cells, commonly used 
by many laboratories for isolation and propagation of Chlamydiae. Therefore, improvement of 
the isolation protocol appears to be possible, and adaptation of the procedure to the origin of 
the isolates is recommended. These findings are valuable for successfully isolating 
Chlamydia, including Tc
R
 C. suis strains, from field samples, and subsequent identification 
and characterization for epidemiological purposes. 
Furthermore, other factors can complicate the evaluation of antibiotic resistance. As 
mentioned earlier, antibiotic treatment of chlamydial infections might induce persistence, 
resulting in treatment failure and a prolonged infection caused by viable but non-culturable 
Chlamydiae (Chopra et al. 1998; Hogan et al. 2004). Hence, it may be challenging to 
differentiate persistence from potential cases of antibiotic resistance, which might lead to 
erroneous conclusions regarding the antibiotic resistance of a clinical isolate. 
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Treatment of chlamydial infections 
In addition to Tc resistance in C. suis, Chlamydiae can acquire resistance to six major classes 
of antibiotics, through mutations, at least in vitro (Sandoz and Rockey 2010). To counter 
emerging antibiotic resistance among human and animal pathogens in general, new Tc 
analogs, insusceptible to the existent resistance mechanisms, and new agents belonging to 
completely new classes of antimicrobials are frequently examined. However, the development 
of these new therapeutic strategies cannot keep up with the rapidly evolving resistance in 
microorganisms, resulting in more resistant pathogens and increasingly limited treatment 
options. Hence, many alternative antimicrobial therapies are being examined based on the 
inhibition of virulence rather than of bacterial growth. This approach is believed to impose 
less selective pressure for development of bacterial resistance compared to traditional 
procedures. Many strategies to identify these so-called virulence blockers have been reported, 
as described in chapter I. However, only few agents have been investigated for exerting anti-
chlamydial activity. The anti-bacterial effects of transferrins in Gram-positive and Gram-
negative bacteria have already been described (Gonzalez-Chavez et al. 2009; Giansanti et al. 
2012). Moreover, LF and ovoTF have already proven their potential to reduce chlamydial 
infection in vitro and in vivo (Beeckman et al. 2007; Van Droogenbroeck et al. 2008; Van 
Droogenbroeck et al. 2011). Moreover, bactericidal peptides derived from transferrins, such 
as OTAP-92 derived from ovoTF, and lactoferricin B from bLF, have shown to be much more 
effective against Gram-positive and Gram-negative bacteria compared to the intact 
transferrins (Dionysius and Milne 1997; Hoek et al. 1997; Ibrahim et al. 1998; Ibrahim et al. 
2000). However, the anti-chlamydial effect of transferrins towards C. suis remains 
univestigated. Further research, in vitro and in vivo, on the application of transferrins as 
promising alternative treatment of chlamydial infections is recommended. Moreover, the 
performance of kinetic studies to follow the route, course and clinical manifestations of 
C. suis infections in pigs from birth to slaughter on a pig farm, could aid in determining the 
ideal timing, method and route of administration of transferrin treatment. 
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Conclusions and future perspectives 
The prevalence of C. suis in pig herds is widely documented, yet, the zoonotic potential of 
this organism is poorly examined. In chapter II, the endemic presence of C. suis in Belgian 
pig herds was confirmed. Moreover, three viable C. suis isolates were demonstrated in pig 
farmers, which further substantiates the zoonotic potential of C. suis. Furthermore, the tet(C) 
gene was demonstrated in porcine C. suis isolates on three farms, but not in human isolates. 
Given the emerging Tc resistance in C. suis and the possible associated public health 
concerns, future research should focus on the zoonotic transmission and significance of 
C. suis infections in humans, based on evaluation of the serological response to C. suis 
infections in a larger human risk population. Moreover, monitoring of Tc
R
 C.suis in pig 
farming is advisable. Further efforts to increase the awareness of the implications of porcine 
chlamydial infections, and to restrict therapeutic use of Tcs in the veterinary field are 
recommended. 
The isolation of viable chlamydial organisms in culture remains crucial for the 
characterization and pathogenicity studies of new isolates. However, the isolation of C. suis 
from field samples is often fastidious, and the available data on the growth conditions of 
C. suis strains in culture are limited. Therefore, in chapter III, the replication of three 
laboratory strains of C. suis were compared in six cell lines of distinct origin. According to 
these results, the growth performance in the investigated cell lines varied among the C. suis 
strains. This variation may be the consequence of the high degree of genetic diversity within 
the species C. suis, which could also explain the high variation in reported virulence of 
distinct C. suis strains. Therefore, we need to advance our knowledge of C. suis pathogenesis, 
including the role of co-infections, and further examine the link between the causative strain 
and the associated pathology. In the near future, the genome sequence of additional C. suis 
strains, apart from the MD56 strain, will become available and will certainly contribute to 
elucidate these issues. Moreover, as mentioned above, kinetic studies on the course and 
clinical and economic implications of C. suis infections in pigs in the field, may further 
improve our knowledge on porcine chlamydial infection biology. Interestingly, pig breed 
dependent susceptibility for pseudorabies virus (Reiner et al. 2002b), porcine reproductive 
and respiratory syndrome virus (Halbur et al. 1998), E. coli (Duchet-Suchaux et al. 1991; 
Michaels et al. 1994) and Sarcocystis miescheriana (Reiner et al. 2002a) has been observed, 
and might thus also influence Chlamydia associated pathology in pigs, suggesting further 
investigation. 
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The widespread emergence of Tc
 
resistance in
 
C. suis in pigs herds endangers the efficient 
treatment of chlamydial infections. Several promising compounds have been identified as 
alternative to failing antibiotic treatment. Further research on the development of therapeutics 
for chlamydial infections should be promoted. The optimal approach to counter chlamydial 
infections in pigs would be through vaccination. Currently, no vaccines for protection against 
C. suis infection are available. However, genital infection of pigs with C. suis S45 induces 
cellular and humoral immune responses, that provide a certain level of protection against re-
infection (De Clercq et al. 2014). These promising findings suggest that the development of a 
C. suis vaccine, eliciting adequate protection against infection, might have a significant 
success rate. 
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Summary 
Chlamydiaceae are Gram-negative obligate intracellular bacteria causing disease in a broad 
range of animals, including humans. Chlamydiaceae infections are widespread in pig farming 
throughout the world, where they cause marked economic losses (Schautteet and Vanrompay 
2011). This thesis focuses on Chlamydia (C.) suis, the most prevalent chlamydial species 
occurring in pigs, and considered as endemic in the intestinal flora of swine (Schautteet and 
Vanrompay 2011). The primary pathogenicity of C. suis for the conjunctiva, respiratory 
system, gastrointestinal and urogenital tract has been demonstrated in various experimental 
infection studies in gnotobiotic and conventionally raised pigs (Rogers and Andersen 1996; 
Rogers et al. 1996; Rogers and Andersen 1999; 2000; Sachse et al. 2004; Reinhold et al. 
2008; Guscetti et al. 2009). Moreover, natural chlamydial infections in pigs have been 
associated with conjunctivitis, arthritis, pericarditis, polyserositis, pneumonia, enteritis, 
diarrhea and reproductive failure (Willigan and Beamer 1955; Sarma et al. 1983; Woollen et 
al. 1990; Zahn et al. 1995; Andersen 1998; Eggemann et al. 2000b). However, the majority of 
chlamydial infections, especially intestinal infections, is believed to be subclinical (Pospischil 
and Wood 1987; Szeredi et al. 1996; Nietfeld et al. 1997; Hoelzle et al. 2000; Camenisch et 
al. 2004a; Englund et al. 2012). Chlamydiaceae are generally highly sensitive to tetracycline 
(Tc), which is the current drug of choice to treat chlamydial infections in lifestock and 
humans, due to its low cost, high effectiveness, low toxicity and broad spectrum of activity 
(Chopra and Roberts 2001; Michalova et al. 2004). However, tetracycline resistant (Tc
R
) 
C. suis strains have been isolated in pig production in the U.S. and throughout Europe 
(Andersen 1998; Di Francesco et al. 2008; Borel et al. 2012; Schautteet et al. 2012), leading 
to treatment failure. The emergence of Tc
R
 C. suis strains also implies a possible hazard for 
public health. Chlamydia suis is phylogenetically highly related to the human pathogen 
C. trachomatis (Everett et al. 1999), and therefore believed to be a potential zoonotic 
bacterium. If zoonotic transfer of C. suis to C. trachomatis infected humans occurs, transfer of 
the Tc resistance gene to C. trachomatis might be facilitated, leading to the creation of 
Tc
R
 C. trachomatis strains. This would affect millions of people worldwide, suffering from 
ocular or genital C. trachomatis infections (Mabey 2008; WHO 2012). Therefore, 
surveillance of the spread of Tc
R
 C. suis into commercial pigs and evaluation of the zoonotic 
potential of C. suis is recommended to assess the associated risks and appropriate measures. 
Chapter I gives a brief overview of the taxonomy and biology of chlamydial infections, 
followed by a short overview of some aspects of the developmental cycle. Furthermore, the 
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occurrence of Chlamydiaceae species in pigs is described with a focus on the diagnosis, 
epidemiology, pathology, antibiotic resistance and zoonotic transmission. The final part of 
this chapter overviews the current chlamydial virulence blocking strategies. 
In Chapter II, we examined the zoonotic transfer of C. suis to pig farmers on nine Belgian 
pig farms, using Chlamydia culture and a C. suis specific real-time PCR in both pigs and 
humans. Moreover, farmers were examined using a C. trachomatis PCR. Additionally, the 
Chlamydia isolates were tested for the presence of the tet(C) resistance gene. Chlamydia suis 
DNA was demonstrated in pigs on all farms, and eight of nine farmers were positive in at 
least one anatomical site. None of the farmers tested positive for C. trachomatis. 
Chlamydia suis isolates were obtained from pigs of eight farms. Nine porcine Tc
R
 C. suis 
strains were retrieved, originating from three farms. Moreover, three human C. suis isolates 
were identified, including one pharyngeal and two rectal isolates. These findings suggest 
further research on the zoonotic transfer of C. suis from pigs to humans. 
In Chapter III, we examined the growth of C. suis in cell culture. The identification of viable 
bacteria through isolation of chlamydial pathogens in cell culture remains crucial for the 
generation of new isolates and their characterization and pathogenesis studies. However, the 
reports on growth conditions of C. suis strains are limited, and isolation of C. suis from field 
samples is often fastidious (Sandoz and Rockey 2010). We examined the growth 
characteristics of a conjunctival, respiratory and intestinal C. suis strain in six different cell 
lines, and compared two chlamydial growth media. Our results suggest that the preferred cell 
line for propagation of C. suis differs among strains, and may be divergent from the cell lines 
currently applied. Furthermore, the use of IMDM chlamydia culture medium may increase the 
replication of C. suis, yet, this effect is strain and cell type dependent. According to these 
results, an adaptation of the currently used isolation methods to the origin of the concerning 
C. suis isolate would be appropriate. 
Finally, Chapter IV describes our conclusions and perspectives for further research. 
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Samenvatting 
Chlamydiaceae zijn Gram-negatieve obligaat intracellulaire bacteriën die ziekte kunnen 
veroorzaken bij mens en dier. Infecties zijn ook wijdverspreid in commerciële varkens over 
heel de wereld, en kunnen leiden tot economische verliezen (Schautteet, K. and Vanrompay 
2011). Deze thesis richt zich op Chlamydia (C.) suis, het meest prevalente chlamydiale 
species in varkens, dat als endemisch wordt beschouwd in hun intestinale flora (Schautteet, K. 
and Vanrompay 2011). De primaire pathogeniciteit van C. suis voor de conjunctiva, het 
ademhalingsstelsel, het gastrointestinaal en urogenitaal stelsel werd door verschillende 
experimentele infecties aangetoond in gnotobiotische en conventioneel gefokte biggen 
(Rogers and Andersen 1996; Rogers et al. 1996; Rogers and Andersen 1999; 2000; Sachse et 
al. 2004; Reinhold et al. 2008; Guscetti et al. 2009). Bovendien zijn natuurlijke Chlamydia 
infecties in varkens geassocieerd met conjunctivitis, arthritis, pericarditis, polyserositis, 
pneumonia, enteritis, diarree en voortplantingsstoornissen (Willigan and Beamer 1955; Sarma 
et al. 1983; Woollen et al. 1990; Zahn et al. 1995; Andersen 1998; Eggemann et al. 2000). 
Echter, de meerderheid van de infecties, voornamelijk intestinale infecties, wordt beschouwd 
als subklinisch (Pospischil and Wood 1987; Szeredi et al. 1996; Nietfeld et al. 1997; Hoelzle 
et al. 2000; Camenisch et al. 2004; Englund et al. 2012). Chlamydiaeceae zijn over het 
algemeen gevoelig voor tetracycline antibiotica, wat op dit moment dan ook het middel bij 
uitstek is om Chlamydia infecties in dieren en mensen te behandelen, door de lage kostprijs, 
hoge effectiviteit, lage toxiciteit en breed spectrum van activiteit (Chopra and Roberts 2001; 
Michalova et al. 2004). Echter, tetracycline resistente (Tc
R
) C. suis stammen, die leidden tot 
het falen van de behandeling, werden reeds geïsoleerd in de varkenshouderij in de V.S. en 
Europa (Andersen 1998; Di Francesco et al. 2008; Borel et al. 2012; Schautteet, K et al. 
2012). Het opduiken van Tc
R
 C. suis stammen vormt ook een mogelijk gevaar voor de 
volksgezondheid. Chlamydia suis is fylogenetisch sterk verwant met de menselijke pathogen 
C. trachomatis (Everett et al. 1999), en wordt daarom beschouwd als een mogelijk 
zoonotische bacterie. Als zoonotische transfer van C. suis naar C. trachomatis geïnfecteerde 
patiënten plaatsvindt, is ook transmissie van het Tc resistentie gen naar C. trachomatis 
mogelijk. Het ontstaan en verspreiding van deze Tc
R
 C. trachomatis stam zou gevolgen 
hebben voor de miljoenen mensen wereldwijd die lijden aan oculaire of genitale 
C. trachomatis infecties (Mabey 2008; WHO 2012). Monitoring van de verspreiding van Tc
R
 
C. suis in commerciële varkens en evaluatie van het zoonotisch potentieel van C. suis is 
daarom van cruciaal belang om het risico in te kunnen schatten en de geschikte maatregelen te 
nemen. 
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Hoofdstuk I start met een kort overzicht van de taxonomie en biologie van Chlamydia 
infecties, gevolgd door een beschrijving van de belangrijkste aspecten van de 
ontwikkelingscyclus. Daarnaast wordt ook het voorkomen van Chlamydiaceae species in 
varkens beschreven met de nadruk op de diagnose, epidemiologie, pathologie, antibioticum 
resistentie and zoonotische transmissie. Het finale deel van dit hoofstuk geeft een overzicht 
van de huidige virulentie blokkeringsstrategiën voor Chlamydia. 
In Hoofdstuk II, hebben we de zoonotische transfer van Chlamydia suis naar varkenshouders 
onderzocht op negen Belgische bedrijven, aan de hand van Chlamydia cultuur en een 
Chlamydia suis specifieke real-time PCR in zowel varkens als de mens. Bovendien werd 
infectie met C. trachomatis in de varkenshouders nagegaan door middel van PCR. Daarnaast, 
werden de bekomen Chlamydia isolaten ook onderzocht voor de aanwezigheid van het tet(C) 
resistentie gen. Chlamydia suis DNA werd aangetoond in varkens op alle bedrijven en acht 
van de negen varkenshouders bleken positief voor minstens één staal. Geen enkele van de 
varkenshouders was besmet met C. trachomatis. Chlamydia suis isolaten werden bekomen 
van varkens van acht bedrijven, en waaronder negen Tc
R
 C. suis stammen, afkomstig van drie 
verschillende bedrijven. Hiernaast werden ook drie C. suis isolaten bekomen van de 
varkenshouders, waaronder één faryngeaal en twee rectale isolaten. Deze resultaten 
suggereren de nood aan verder onderzoek omtrent de zoonotische transfer van C. suis van het 
varken naar de mens.  
In Hoofdstuk III hebben we de groei van C. suis in celcultuur bestudeerd. De identificatie 
van levende bacteriën via isolatie in celcultuur blijft cruciaal voor de opgroei en karakterisatie 
van nieuwe isolaten en studie van de geassocieerde pathogenese. De beschikbare informatie 
over optimale groeicondities van C. suis stammen is echter zeer beperkt, en isolatie van 
C. suis uit veldstalen is vaak erg moeilijk (Sandoz and Rockey 2010). Daarom hebben we de 
groeikarakteristieken bepaald voor een conjunctivale, respiratoire en intestinale C. suis stam 
in zes verschillende cellijnen, en hierbij twee Chlamydia groei media vergeleken. Onze 
resultaten suggereren dat de meest geschikte cellijn voor opkweek van C. suis verschilt tussen 
de stammen, en afwijkt van de cellijnen die op dit moment routinematig gebruikt worden voor 
de opkweek van C. suis. Daarnaast kan ook het gebruik van IMDM Chlamydia cultuur 
medium de replicatie van C. suis verbeteren, echter, dit effect is stam- en celtype afhankelijk. 
Uit deze resultaten blijkt dat het afstemmen van de isolatiemethode op de oorsprong van de te 
analyseren stalen aangeraden is. 
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Hoofdstuk IV beschrijft tenslotte onze conclusies en perspectieven voor verder onderzoek. 
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